E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the ‘common liability’ theory

Hui G. Cheng; Edward G. Largo; Maria Gogova

doi:10.12688/f1000research.21377.1

Home Browse E-cigarette use and onset of first cigarette smoking among adolescents:...

ALL Metrics

Views

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the ‘common liability’ theory

[version 1; peer review: 2 approved with reservations]

Hui G. Cheng ¹, Edward G. Largo¹, Maria Gogova¹

PUBLISHED 13 Dec 2019

Author details Author details

¹ Regulatory Sciences, Altria Client Services, Richmond, VA, 23219, USA

Hui G. Cheng
Roles: Conceptualization, Data Curation, Formal Analysis, Methodology, Software, Writing – Original Draft Preparation, Writing – Review & Editing

Edward G. Largo
Roles: Conceptualization, Resources, Supervision, Writing – Review & Editing

Maria Gogova
Roles: Conceptualization, Methodology, Resources, Supervision, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Background: E-cigarettes have become the most commonly used tobacco products among youth in the United States (US) recently. It is not clear whether there is a causal relationship between e-cigarette use and the onset of cigarette smoking. The “common liability” theory postulates that the association between e-cigarette use and cigarette smoking can be attributed to a common risk construct of using tobacco products. This study aims to investigate the relationship between ever e-cigarette use and cigarette smoking onset in the US using a structural equation modeling approach guided by the “common liability” theory.
Methods: The study population is non-institutionalized civilian adolescents living in the US, sampled in the longitudinal Population Assessment of Tobacco and Health study. Information about tobacco product use was obtained via confidential self-report. A structural equation modeling approach was used to estimate the relationship between e-cigarette use at wave 1 and the onset of cigarette smoking at wave 2 after controlling for a latent construct representing a “common liability to use tobacco products.”
Results: After controlling for a latent construct representing a “common liability to use tobacco products”, ever e-cigarette use does not predict the onset of cigarette smoking (β=0.10, 95% CI= -0.09, 0.29, p=0.299). The latent “common liability to use tobacco products” is a robust predictor for the onset of cigarette smoking (β=0.42; 95% CI=0.08, 0.76; p=0.015).
Conclusions: Findings from this study provide supportive evidence for the ‘common liability’ underlying observed associations between e-cigarette use and smoking onset.

Keywords

Adolescents, e-cigarette, cigarette smoking, common liability theory

Corresponding author: Hui G. Cheng

Competing interests: All authors are full-time employees of Altria Client Services LLC.

Grant information: The study is supported by Altria Client Services LLC.

Copyright: © 2019 Cheng HG et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Cheng HG, Largo EG and Gogova M. E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the ‘common liability’ theory [version 1; peer review: 2 approved with reservations]. F1000Research 2019, 8:2099 (https://doi.org/10.12688/f1000research.21377.1) First published: 13 Dec 2019, 8:2099 (https://doi.org/10.12688/f1000research.21377.1) Latest published: 23 Jun 2020, 8:2099 (https://doi.org/10.12688/f1000research.21377.3)

Introduction

The prevention of underage cigarette smoking is an essential component to curtail the substantial disease burden associated with cigarette smoking¹. The prevalence of underage cigarette smoking has been declining in the US over the past two decades². E-cigarettes (or e-vapor products) were introduced to the market as potentially reduced-harm alternatives to combustible cigarettes and have gained popularity since they became generally accessible around 2009^3,4. In the US, the prevalence of youth e-cigarette use increased sharply between 2011 and 2015 and, after a brief decline, increased again in 2018^3,4. Multiple national surveys have shown that the majority of e-cigarette use is infrequent or experimental^4–6. Despite this, the existence of exclusive e-cigarette users who do not use other tobacco products raises concerns about whether e-cigarettes may play a causal role in the uptake of cigarette use and, therefore, offset the decline in underage cigarette use.

A review of existing literature revealed some inconsistencies in evidence about the relationship between e-cigarette use and cigarette smoking. To infer causality, studies with an experimental design arguably provide the best evidence. Nonetheless, a randomized controlled trial of e-cigarette use among nonusers is not feasible⁷. In this context, Vasiljevic and colleagues sought to evaluate the impact of exposure to advertisements promoting e-cigarettes on appeal and susceptibility of tobacco smoking using an experimental design. Youth (11–16 years of age) nonusers of e cigarettes and combustible cigarettes were randomized to e-cigarette advertisement groups (a candy-flavored e-cigarette advertisement group and a non-flavored e-cigarette advertisement group), or to a no advertisement group (control). This study found no effect of exposure to e-cigarette advertisements on appeal or susceptibility of cigarette smoking. Moreover, it had no effect on the perceived harm of cigarette smoking, another robust predictor for cigarette smoking onset⁸. Despite the lack of direct behavioral measures, this study suggests that the exposure to e-cigarette advertisement had no acute effect on the measures related to cigarette smoking.

The largest body of literature comes from individual-level observational studies showing a consistent positive association linking e-cigarette use with a higher risk of cigarette smoking onset, even after adjusting for a range of variables known to be associated with cigarette smoking^9–12. In a systematic review and meta-analysis, Soneji and colleagues (2017) concluded that e-cigarette ever use was associated with greater risk for subsequent cigarette initiation and past 30-day use¹³. Nonetheless, in the context of observational studies, it is almost impossible to control for an exhaustive list of confounders; the positive relationship can be attributed to unmeasured confounders associated with e-cigarette use, which would produce a spurious relationship between e-cigarette use and cigarette smoking without the presence of a causal relationship^7,14.

Ecological prevalence trends are inconsistent with the notion that e-vapor use increases cigarette smoking. At the country level, e-cigarettes emerged and gained popularity during the period when the sharpest decline in adolescent cigarette smoking was observed in the US and other countries^5,15,16. To further quantify the potential change over time, Dutra and Glantz applied interrupted time series analysis using data from National Youth Tobacco Surveys, 2004–2014, and found no difference in the rate of decline in ever (p=0.57) or current (p=0.23) cigarette smoking before and after 2009, when e-cigarette became available in the US market². That is, the rate of decline in youth cigarette smoking did not change after the emergence of e-cigarette. In addition to country-level analysis, Dutra and Glantz used individual-level data to build a prediction model based upon data from the pre-e-cigarette era (2004–2009). This model correctly predicted ~70% of ever smokers and ~75% of current smokers for the post-e-cigarette era (i.e., 2010 to 2014). These predictions are similar to the predictions for the pre-e-cigarette era (i.e., 2004 to 2009). This finding suggests that smokers’ characteristics did not change before and after the introduction of e-cigarettes. Although e-cigarettes became available in the US in 2009, e-cigarette use was uncommon between 2009 and 2013. Levy and colleagues specified 2014, when e-cigarette use became prominent among youth in the US, as the reference time point and assessed the relationship between e-cigarette prevalence and cigarette smoking prevalence at an ecological level¹⁷. In this study, they found strong inverse associations between the prevalence of e-cigarette use and the prevalence of cigarette smoking among adolescents and young adults. Moreover, the inverse associations were consistently shown in all US national surveys identified via a systematic literature search¹⁷. Also at the ecological level, a few studies compared youth cigarette smoking prevalence between states with and without regulations to prohibit sales of e-cigarettes to minors, with the assumption that cigarette smoking prevalence should be higher in states that are less-restrictive toward underage access to e-cigarettes if e-cigarette use increases the risk of cigarette smoking. These studies have produced inconsistent findings with two studies documenting lower youth cigarette smoking in states without an e-cigarette age restriction^18,19, and one study documenting the opposite²⁰. Nonetheless, it is well known that ecological studies are prone to “ecological fallacy”, which may introduce inconsistent findings for causal inference.

One potential explanation of the consistently observed association between e-cigarette use and cigarette smoking from individual observational studies is the “common liability” theory, which postulates that any observed relationships between e-cigarettes and combustible tobacco cigarettes is attributed to the “liability” to use tobacco products of the individual; once this “common liability” is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking^21–24. Several lines of evidence align with the “common liability” theory. First, the relationship is not unique to e-cigarettes. Various studies showed that the use of any type of tobacco products (e.g., cigar, hookah, etc.) and/or other substances (e.g., alcohol and cannabis) predicted cigarette smoking onset (e.g., 11,12,24,25). Moreover, the risk of cigarette smoking onset increases with the number of types of tobacco product used¹¹. Findings from a recent study using a propensity scoring approach found supportive evidence that the frequently observed association between e-cigarette use and smoking is largely attributed to shared risk factors, using data from Monitoring the Future, a national school survey of 8^th, 10^th, and 12^th graders²⁶. Second, the relationships between cigarette smoking and e-cigarette use are often reciprocal. For example, Leventhal and colleagues (2015) found that high school never triers of combustible tobacco products who had ever used e-cigarettes were more likely to start using any combustible tobacco product at 6- and 12-month follow-up than those who had never used e-cigarettes at baseline. Likewise, among never triers of e-cigarettes at baseline, those who had ever used combustible tobacco products were more likely to start e-cigarette use at follow-ups than those who had never used combustible tobacco products²⁷. This bidirectional relationship has been replicated in some more recent studies^12,28,29. Third, e-cigarette use predicts the onset of a range of other substance use behaviors, not limited to cigarette smoking^10,25. These lines of evidence support the notion that the relationship is not limited or specific to e-cigarettes, and common risk factors may underlie the use of various tobacco products³⁰.

Poorer inhibitory control and elevated impulsivity are phenotypes of externalizing problems, which has been linked to precocious use of various substances^31–34. A study found similar levels of inhibitory control and impulsivity between youth e-cigarette users who never smoked a cigarette and youth smokers who never used an e-cigarette. Both groups showed poorer inhibitory control and elevated impulsivity compared to youth not using any tobacco products³⁵.

Given this background and guided by the ‘common liability’ theory, the aim of this study is to estimate the prospective relationship between e-cigarette ever use and the onset of cigarette smoking after controlling for a “common liability” to use tobacco in US adolescents using a structural equation modeling approach. In essence, we first created a unidimensional construct to represent the ‘liability’ to use tobacco products, and then regressed the onset of cigarette use on antecedent e-cigarette use taking into account the latent ‘liability’ to use tobacco products.

Methods

Study population and sample

The study population consisted of non-institutionalized civilian adolescents 12–17 years of age living in the US, sampled in the longitudinal Population Assessment of Tobacco and Health (PATH) study. A multi-stage sampling method was used to draw nationally representative samples after Institutional-Review-Board-approved parent consent and youth assent³⁶. In contrast to school surveys of adolescents, the PATH sample includes young people irrespective of school attendance, and its sampling frame includes college dormitories and children of active-duty military living in the US. More details about the PATH methodology is provided elsewhere³⁶.

In this study, PATH wave 1 (2013–2014) and wave 2 (2014–2015) data were used. Participation levels were 54% at the household level and 78% at the individual level for the youth survey at wave 1. Wave 2 follow-up rate was 88% for youth. Because the outcome in this study is the onset of cigarette smoking, the study sample consists of wave 1 never smokers who were followed up at wave 2. We did not include “aged-up” adolescents (i.e., those who became 18 at wave 2) to retain a sample relevant for underage smoking (n=9,045).

Assessments

PATH confidential assessments were audio computer assisted self-interviews (ACASI), with standardized multi-item modules on use of various tobacco products, including cigarettes, e-cigarettes, cigars (including traditional cigars, cigarillos, and filtered cigars), smokeless tobacco, snus, hookah, pipe, dissolvable tobacco, bidis, and kretek. Survey questions about ever use of these tobacco products are typically in the format of “Have you ever smoked/used …, even one or two puffs/times?” In this study, the outcome is the onset of ever cigarette smoking at wave 2, which is defined as smoking cigarettes (even one or two puffs) for the first time between wave 1 and wave 2 assessments among adolescents who had never smoked cigarettes at wave 1. PATH also assessed lifetime history (i.e., ever use) of alcohol, cannabis, Ritalin^® or Adderall^®, Painkillers/sedatives/tranquilizers, cocaine, stimulants, and other drugs, respectively.

Sex (male or female) and age categories (12–14 or 15–17 years of age at baseline) were included as covariates. (The PATH Public Use File only included a binary variable for age.) Information about these covariates is from survey items in the Demographics module. When these items are missing, information from the household screening roster is drawn.

Analysis approach

Guided by the “common liability” theory, we used a structural equation modeling approach to test whether there is a specific association between e-cigarette ever use at wave 1 and the onset of first cigarette smoking at wave 2 holding constant a latent construct for the “liability to use tobacco products.”

First, we built a latent construct for the common liability to use tobacco products using confirmatory factor analysis methods. The observed variables were lifetime ever use of specific tobacco products. All tobacco products assessed in PATH wave 1 were included to create the latent construct. Snuff and chewing tobacco, snus, and dissolvable tobacco products were combined to create a “smokeless tobacco products” variable due to the considerations that a) youth participants may not differentiate these oral tobacco products well, and b) low occurrence of dissolvable tobacco use (n=9) and high correlation between smokeless tobacco use and snus use (i.e., 69% of snus users had also used smokeless tobacco). All observed variables were treated as categorical variables. The variance of the latent construct was fixed to one in order to obtain factor loading and threshold estimates for each observed variable. After ensuring a good fit of the measurement model (as described in the next paragraph), we built the structural portion of the model to assess the relationship between e-cigarette ever use at wave 1 and the onset of first cigarette smoking at wave 2. Specifically, we drew a path from the latent construct to the onset of first cigarette smoking as well as a direct path from e-cigarette ever use to the onset of first cigarette smoking. Figure 1 provides a conceptual description of the model. If the direct path from e-cigarette to cigarette smoking is statistically robust, it provides evidence that e-cigarettes plays a role for cigarette smoking onset over and beyond the common liability to use tobacco products. If not, it supports the notion that the frequently observed association between e-cigarettes ever use and smoking is attributed to a common liability to use tobacco products.

Figure 1. Depiction of a conceptual structural equation model to predict the onset of first cigarette smoking by e-cigarette use adjusting for a latent ‘liability to use tobacco’ construct.

Several model fit indices were used to assess the goodness of fit of the measurement and the final structural models. These fit indices include root mean square of approximation (RMSEA)³⁷, comparative fit index (CFI)³⁸, and Tucker-Lewis index (TLI) . A RMSEA<0.08 and CFI/TLI > 0.90 are considered as indications of reasonably good model fit^39,40.

Analysis weights were used to adjust for selection probability, nonresponse patterns, possible deficiencies in the sampling frame, and attrition. The PATH User Guide provides details about the calculation of weights³⁶. Balanced repeated replication method was used to generate standard errors and 95% confidence intervals (CI). Analyses were conducted using Stata 15.0 (StataCorp, College Station, Texas, USA) and Mplus 8.1 (Muthén & Muthén, Los Angeles, CA, USA).

Results

Table 1 presents the estimated ever use of tobacco products as well as factor loadings and thresholds from confirmatory factor analysis among youths who had never tried a cigarette at wave 1 (n=9,045). Among the sample of youth never smokers, e-cigarette was the most common tobacco product ever tried (3.7%), followed by hookah (2.5%), with bidi and kretek being the least common tobacco products ever tried (0.1%). The measurement model fits reasonably well (RMSEA=0.019, 90% CI=0.014, 0.024; CFI=0.963; TLI=0.945); all factor loadings were greater than 0.4 and statistically significant (p<0.001). Each individual’s factor score, a score reflecting the latent liability to use tobacco products, was calculated based on both the threshold and the loading of each item. Therefore, an individual who used bidi, kretek, or pipe (items with greater thresholds) would have a higher factor score compared to an individual who used e-cigarette or hookah only (items with lower thresholds). An individual who used multiple products would generally have a higher factor score than an individual who used a single product. This factor score represents an individual’s liability (unobserved) to use tobacco products.

Table 1. Estimated occurrence (%) of lifetime ever use of tobacco products, factor loadings, and thresholds from confirmatory factor analysis.

Data from Population Assessment of Tobacco and Health wave 1 and 2, 2013–2015⁴¹. (Unweighted n=9,045 12–17 Year Olds^a).

Ever use of	Weighted %	Standardized factor loading	Standardized threshold
E-cigarette	3.7	0.76	1.78
Cigar	1.3	0.71	2.23
Pipe	0.3	0.88	2.77
Hookah	2.5	0.62	1.97
Smokeless tobacco products^b	1.2	0.63	2.22
Bidi	0.1	0.45	3.27
Kretek	0.1	0.68	3.28

^a Analytical sample consists of youths who had never smoked a puff of cigarette at wave 1 and followed up and remained youths at wave 2.

^b smokeless tobacco includes smokeless tobacco, snus, and dissolvable tobacco products.

Of the 9,045 never cigarette smokers at wave 1 assessment, 338 adolescents smoked a cigarette for the first time between wave 1 and wave 2 assessments (weighted incidence= 3.8%). The structural equation model shown in Figure 1 fits data well (RMSEA=0.015, 90% CI=0.011, 0.020; CFI=0.969; TLI=0.954). The model shows that after accounting for the general liability to use tobacco products, e-cigarette ever use at wave 1 is not associated with cigarette onset at wave 2 (β=0.13; 95% CI= -0.07, 0.32; p=0.204). The latent general liability variable is positively associated with wave 2 onset of ever cigarette smoking (β=0.38; 95% CI=0.07, 0.69; p=0.015). Because sex and age are the two most important exogenous variables that are related to tobacco use behaviors, they were introduced as covariates in the next step to assess any potential changes in estimates and statistical inference. Including sex and age as covariates introduced little change in estimates, and statistical inference remained the same (β=0.16; 95% CI= -0.03, 0.35; p=0.095; for the e-cigarette to cigarette onset path; β=0.33; 95% CI= 0.04, 0.61; p=0.025; for the ‘liability to use tobacco’ latent construct to cigarette onset path).

In order to further test the model with a latent construct for the liability for use of psychoactive substances (as was originally proposed by the ‘common liability theory’), we expanded the measurement model to include other substances measured in PATH (i.e., alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs (heroin, inhalants, solvents, and hallucinogens). The expanded measurement and structural equation models both have good fit (RSMEA<0.02, CFI and TLI>0.90; see Table 2 for estimated ever use, factor loadings, and thresholds). Similar to results from the tobacco liability model shown above, the e-cigarette-specific path is not statistically significant (β=0.13; 95% CI= -0.002, 0.27; p=0.053 without adjusting for sex and age; β=0.14; 95% CI= -0.002, 0.29; p=0.054 with adjusting for sex and age), and the latent ‘liability’ construct is a robust predictor of cigarette smoking onset (β=0.44; 95% CI=0.28, 0.61; p<0.001 without adjusting for sex and age; β=0.43; 95% CI=0.25, 0.60; p<0.001 with adjusting for sex and age).

Table 2. Estimated occurrence (%) of lifetime ever use of tobacco products, alcohol, cannabis, and other psychoactive drugs, factor loadings, and thresholds from confirmatory factor analysis.

Data from Population Assessment of Tobacco and Health wave 1 and 2, 2013–2015⁴¹. (Unweighted n=9,045 12– 17 Year Olds^a).

Ever use of	Weighted %	Standardized factor loading	Standardized threshold
E-cigarette	3.7	0.70	1.78
Cigar	1.3	0.72	2.23
Pipe	0.3	0.70	2.77
Hookah	2.5	0.68	1.97
Smokeless tobacco products^b	1.2	0.59	2.22
Bidi	0.1	0.46	3.27
Kretek	0.1	0.76	3.27
Alcohol	29.1	0.60	0.55
Cannabis	4.8	0.84	1.66
Prescription Ritalin and Adderall	1.1	0.53	2.29
Cocaine/crack	0.1	0.81	3.05
Stimulants	0.1	0.79	3.00
Other drugs^c	0.2	0.65	2.93

^a Analytical sample consists of youths who had never smoked a puff of cigarette at wave 1 and followed up and remained youths at wave 2.

^b Smokeless tobacco products includes snuff and chew, snus, and dissolvable tobacco products.

^c Other drugs include heroin, inhalants, solvents, and hallucinogens.

Discussion

In this study, we found that after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.

Limitations and strengths

This study’s findings should be interpreted in light of the following limitations.

First, this study is observational in nature. Unmeasured heterogeneity is possible (variables not accounted for by the latent ‘liability’ construct), and no definitive evidence for a causal relationship is warranted. Second, the assessment was based on self-report information. There is possible under-reporting of tobacco and other drug use due to socially desirable responding⁴². The use of ACASI can help ameliorate this limitation. Measures for ever use of tobacco products have been shown to have good validity based on self-reported information⁴³. Third, the response level at the household screening is moderate. Nonetheless, it is comparable to other modern national household surveys in the US⁴⁴, and post-stratification was applied to bring the sample into balance with the US adolescent population.

Strengths of this study include a) the prospective design provides clear temporal relationship, and is less prone to differential recall as compared to cross-sectional surveys; b) compared to prevalence-based measures, newly incident cigarette use focuses on the onset process without any interference of the persistence process⁴⁵; c) by using nationally representative data, our results are generalizable to the general US adolescent population; and d) the use of ACASI and relatively low attrition in PATH enhances internal validity by reducing potential socially desirable responding and bias associated with attrition.

Our approach is driven by the “common liability” theory. To the best of our knowledge, this is the first study to use a structural equation modeling approach to create a latent unidimensional ‘liability’ variable, which is consistent with the conceptualization of “liability”, which denotes “a latent (unobservable) quantitative trait that, when measured, ‘would give us a graded scale of the degree of affectedness or of normality’^24,46.”

Tobacco products use is the result of complex genetic-environment interplay. Under the “common liability” conceptualization, the sequence of tobacco product use is opportunistic and depends upon various environmental factors including accessibility, local policies, and social norms. Therefore, the threshold for each product may change from one culture to other. For example, in a cigar-prone culture, the threshold for cigar use may be lower than that for e-cigarettes. The latent ‘liability’ construct is capable of accommodating these types of environmental variations.

Interpretation of findings, implications, and future directions

A few hypotheses have been developed to provide theoretical grounds and underlying mechanisms for the relationship between e-cigarette use and subsequent cigarette smoking among youth. Here, we highlight three main theories as cited by the Academies of Sciences Engineering Medicine: the ‘diversion theory’, ‘catalyst theory’, and ‘common liability theory’⁴⁷. In brief, the ‘diversion theory’ hypothesizes that e-cigarette deters tobacco cigarette use by diverting ‘high-risk’ individuals to e-cigarette from combustible cigarettes^22,48. The ‘catalyst theory’ postulates that e-cigarette use increases the risk of combustible cigarette use by first attracting ‘low-risk’ individuals to e-cigarettes, as a reduced-harm product, and then increasing proclivity to try combustible tobacco cigarettes⁴⁹. The ‘common liability theory’ proposes that any observed relationships between e-cigarettes and combustible tobacco cigarettes is completely attributed to shared risk factors such as impulsivity and novelty-seeking (e.g., common liability to use tobacco products;^21–24). If the ‘diversion theory’ is true, e-cigarette use should decrease the onset of cigarette smoking (or accelerate the declining trend of smoking); if the ‘catalyst theory’ is true, e-cigarette use should increase the onset of cigarette smoking; if the ‘common liability’ theory is true, a null relationship should be observed. Our findings provide supporting evidence for the ‘common liability’ theory for the US youth population as a whole. Our finding is in line with findings from a recent study using propensity scoring methods, which found supportive evidence that the observed association between e-cigarette use and cigarette smoking was attributed to shared risk factors for tobacco use²⁶. Nonetheless, it is possible that different hypotheses apply to heterogeneous groups of individuals or contexts. For example, e-cigarettes may provide an alternative to cigarette smoking for some adolescents, whereas they may expose some other adolescents to a more smoking-prone environment. The onset of cigarette smoking is a complex interplay between micro-, meso-, and macro-level factors. Future studies with assessments of a breadth of these relevant factors and due attention to potential heterogeneities may provide more insights about the role of e-cigarette in smoking onset to guide targeted prevention and intervention efforts among youth. Applications of similar approaches in other cultures will help assess the reproducibility and consistency of the evidence, which is required for causal inference. It is noteworthy in this context that tobacco use behaviors in youth are often experimental and highly dependent on the availability of tobacco products^6,50–52, and an infrequent use pattern (1–2 days during the past 30 day) is more pronounced among exclusive e-cigarette users compared to youths who use other tobacco products concurrently⁵¹. In this context, future studies incorporating the frequency of e-cigarette use and examining the relationship between e-cigarette use and the progression to more established cigarette smoking will provide useful insights about the e-cigarette-use-and-smoking relationship.

Data availability

Underlying data

National Addiction & HIV Data Archive Program: Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files (ICPSR 36498), https://doi.org/10.3886/ICPSR36498.v9⁴¹.

All data are publicly available. In order to download the data, users must first agree with the ICPSR Terms of Use, specific to each dataset, which can be viewed by clicking the download button. Data used in this study were downloaded on May 14, 2018.

Acknowledgements

A previous version of this work is available from: https://dx.doi.org/10.2139/ssrn.3422321.

Faculty Opinions recommended

References

1. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017; 389(10082): 1885–1906. PubMed Abstract | Publisher Full Text | Free Full Text
2. Dutra LM, Glantz SA: E-cigarettes and National Adolescent Cigarette Use: 2004-2014. Pediatrics. 2017; 139(2): pii: e20162450. PubMed Abstract | Publisher Full Text | Free Full Text
3. Johnston LD, Miech RA, O'Malley PM, et al.: Monitoring the Future national survey results on drug use: 1975-2017: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research. 2018. Reference Source
4. Wang TW, Gentzke A, Sharapova S, et al.: Tobacco Product Use Among Middle and High School Students - United States, 2011-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(22): 629–633. PubMed Abstract | Publisher Full Text | Free Full Text
5. Johnston LD, Miech RA, O'Malley PM, et al.: Teen use of any illicit drug other than marijuana at new low same true for alcohol. 2016. Reference Source
6. Collins LK, Villanti AC, Pearson JL, et al.: Frequency of Youth E-Cigarette, Tobacco, and Poly-Use in the United States, 2015: Update to Villanti et al., "Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health". Nicotine Tob Res. 2017; 19(10): 1253–1254. PubMed Abstract | Publisher Full Text | Free Full Text
7. Warner KE: How to Think-Not Feel-about Tobacco Harm Reduction. Nicotine Tob Res. 2019; 21(10): 1299–1309. PubMed Abstract | Publisher Full Text
8. Vasiljevic M, St John Wallis A, Codling S, et al.: E-cigarette adverts and children's perceptions of tobacco smoking harms: an experimental study and meta-analysis. BMJ Open. 2018; 8(7): e020247. PubMed Abstract | Publisher Full Text | Free Full Text
9. Miech R, Patrick ME, O'Malley PM, et al.: E-cigarette use as a predictor of cigarette smoking: results from a 1-year follow-up of a national sample of 12th grade students. Tob Control. 2017; 26(e2): e106–e111. PubMed Abstract | Publisher Full Text | Free Full Text
10. Leventhal AM, Strong DR, Kirkpatrick MG, et al.: Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015; 314(7): 700–707. PubMed Abstract | Publisher Full Text | Free Full Text
11. Watkins SL, Glantz SA, Chaffee BW: Association of Noncigarette Tobacco Product Use With Future Cigarette Smoking Among Youth in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2015. JAMA Pediatr. 2018; 172(2): 181–187. PubMed Abstract | Publisher Full Text | Free Full Text
12. Berry KM, Fetterman JL, Benjamin EJ, et al.: Association of Electronic Cigarette Use With Subsequent Initiation of Tobacco Cigarettes in US Youths. JAMA Netw Open. 2019; 2(2): e187794. PubMed Abstract | Publisher Full Text | Free Full Text
13. Soneji S, Barrington-Trimis JL, Wills TA, et al.: Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017; 171(8): 788–797. PubMed Abstract | Publisher Full Text | Free Full Text
14. Glasser A, Abudayyeh H, Cantrell J, et al.: Patterns of E-Cigarette Use Among Youth and Young Adults: Review of the Impact of E-Cigarettes on Cigarette Smoking. Nicotine Tob Res. 2019; 21(10): 1320–1330. PubMed Abstract | Publisher Full Text
15. Polosa R, Russell C, Nitzkin J, et al.: A critique of the US Surgeon General's conclusions regarding e-cigarette use among youth and young adults in the United States of America. Harm Reduct J. 2017; 14(1): 61. PubMed Abstract | Publisher Full Text | Free Full Text
16. Jamal A, Gentzke A, Hu SS, et al.: Tobacco Use Among Middle and High School Students - United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2017; 66(23): 597–603. PubMed Abstract | Publisher Full Text | Free Full Text
17. Levy DT, Warner KE, Cummings KM, et al.: Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check. Tob Control. 2019; 28(6): 629–635. PubMed Abstract | Publisher Full Text | Free Full Text
18. Pesko MF, Hughes JM, Faisal FS: The influence of electronic cigarette age purchasing restrictions on adolescent tobacco and marijuana use. Prev Med. 2016; 87: 207–212. PubMed Abstract | Publisher Full Text
19. Friedman AS: How does electronic cigarette access affect adolescent smoking? J Health Econ. 2015; 44: 300–308. PubMed Abstract | Publisher Full Text
20. Abouk R, Adams S: Bans on electronic cigarette sales to minors and smoking among high school students. J Health Econ. 2017; 54: 17–24. PubMed Abstract | Publisher Full Text
21. Etter JF, Bugey A: E-cigarette liquids: Constancy of content across batches and accuracy of labeling. Addict Behav. 2017; 73: 137–143. PubMed Abstract | Publisher Full Text
22. Kozlowski LT, Warner KE: Adolescents and e-cigarettes: Objects of concern may appear larger than they are. Drug Alcohol Depend. 2017; 174: 209–214. PubMed Abstract | Publisher Full Text
23. Vanyukov MM, Ridenour TA: Common liability to drug addictions: theory, research, practice. Drug Alcohol Depend. 2012; 123(Suppl 1): S1–2. PubMed Abstract | Publisher Full Text | Free Full Text
24. Vanyukov MM, Tarter RE, Kirillova GP, et al.: Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 2012; 123(Suppl 1): S3–17. PubMed Abstract | Publisher Full Text | Free Full Text
25. Silveira ML, Conway KP, Green VR, et al.: Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Drug Alcohol Depend. 2018; 191: 25–36. PubMed Abstract | Publisher Full Text | Free Full Text
26. Kim S, Selya AS: The Relationship Between Electronic Cigarette Use and Conventional Cigarette Smoking Is Largely Attributable to Shared Risk Factors. Nicotine Tob Res. 2019; pii: ntz157. PubMed Abstract | Publisher Full Text
27. Leventhal AM, Strong DR, Kirkpatrick MG, et al.: Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015; 314(7): 700–707. PubMed Abstract | Publisher Full Text | Free Full Text
28. Penzes M, Foley KL, Nădășan V, et al.: Bidirectional associations of e-cigarette, conventional cigarette and waterpipe experimentation among adolescents: A cross-lagged model. Addict Behav. 2018; 80: 59–64. PubMed Abstract | Publisher Full Text | Free Full Text
29. East K, Hitchman SC, Bakolis I, et al.: The Association Between Smoking and Electronic Cigarette Use in a Cohort of Young People. J Adolesc Health. 2018; 62(5): 539–547. PubMed Abstract | Publisher Full Text | Free Full Text
30. United States Department of Health and Human Services: Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2012. PubMed Abstract
31. Fischer JA, Najman JM, Williams GM, et al.: Childhood and adolescent psychopathology and subsequent tobacco smoking in young adults: findings from an Australian birth cohort. Addiction. 2012; 107(9): 1669–1676. PubMed Abstract | Publisher Full Text
32. Farmer RF, Seeley JR, Kosty DB, et al.: Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood. Psychol Addict Behav. 2015; 29(3): 541–551. PubMed Abstract | Publisher Full Text | Free Full Text
33. Patrick ME, Schulenberg JE: Prevalence and predictors of adolescent alcohol use and binge drinking in the United States. Alcohol Res. 2013; 35(2): 193–200. PubMed Abstract | Free Full Text
34. Pedersen MU, Thomsen KR, Heradstveit O, et al.: Externalizing behavior problems are related to substance use in adolescents across six samples from Nordic countries. Eur Child Adolesc Psychiatry. 2018; 27(12): 1551–1561. PubMed Abstract | Publisher Full Text
35. Leventhal AM, Strong DR, Sussman S, et al.: Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016; 73: 71–78. PubMed Abstract | Publisher Full Text | Free Full Text
36. United States: Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files User Guide. In: Services DoHaH, ed. Ann Arbor, Michigan 48106: Inter-university Consortium for Political and Social Research. 2017.
37. Steiger JH: Structural Model Evaluation and Modification: An Interval Estimation Approach. Multivariate Behav Res. 1990; 25(2): 173–180. PubMed Abstract | Publisher Full Text
38. Bentler PM: Comparative fit indexes in structural models. Psychol Bull. 1990; 107(2): 238–246. PubMed Abstract | Publisher Full Text
39. Hu Lt, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal. 1999; 6(1): 1–55. Publisher Full Text
40. Bentler PM, Bonett DG: Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980; 88(3): 9. Publisher Full Text
41. United States Department of Health and Human Services; National Institutes of Health; National Institute on Drug Abuse; et al.: Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files. Inter-university Consortium for Political and Social Research [distributor], 2019-11-11. http://www.doi.org/10.3886/ICPSR36498.v9
42. Latkin CA, Vlahov D, Anthony JC: Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993; 88(4): 517–526. PubMed Abstract | Publisher Full Text
43. Adams J, Parkinson L, Sanson-Fisher RW, et al.: Enhancing self-report of adolescent smoking: the effects of bogus pipeline and anonymity. Addict Behav. 2008; 33(10): 1291–1296. PubMed Abstract | Publisher Full Text
44. United States Substance Abuse and Mental Health Services Administration: 2016 National Survey on Drug Use and Health: Methodological summary and definitions. In: Quality. CfBHSa, ed. Rockville, MD: United States Substance Abuse and Mental Health Services Administration; 2017. Reference Source
45. Lapouse R: Problems in studying the prevalence of psychiatric disorder. Am J Public Health Nations Health. 1967; 57(6): 947–954. PubMed Abstract | Publisher Full Text | Free Full Text
46. Falconer D: The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet. 1965; 29(1): 51–76. Publisher Full Text
47. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; et al.: Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018. PubMed Abstract | Publisher Full Text
48. Etter JF: Gateway effects and electronic cigarettes. Addiction. 2018; 113(10): 1776–1783. PubMed Abstract | Publisher Full Text
49. Schneider S, Diehl K: Vaping as a Catalyst for Smoking? An Initial Model on the Initiation of Electronic Cigarette Use and the Transition to Tobacco Smoking Among Adolescents. Nicotine Tob Res. 2016; 18(5): 647–653. PubMed Abstract | Publisher Full Text
50. Abrams DB, Glasser AM, Pearson JL, et al.: Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annu Rev Public Health. 2018; 39: 193–213. PubMed Abstract | Publisher Full Text
51. Villanti AC, Pearson JL, Glasser AM, et al.: Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health. Nicotine Tob Res. 2017; 19(11): 1345–1350. PubMed Abstract | Publisher Full Text | Free Full Text
52. Hair EC, Romberg AR, Niaura R, et al.: Longitudinal Tobacco Use Transitions Among Adolescents and Young Adults: 2014-2016. Nicotine Tob Res. 2019; 21(4): 458–468. PubMed Abstract | Publisher Full Text

Comments on this article Comments (0)

Version 3

VERSION 3 PUBLISHED 13 Dec 2019

Author details Author details

¹ Regulatory Sciences, Altria Client Services, Richmond, VA, 23219, USA

Hui G. Cheng
Roles: Conceptualization, Data Curation, Formal Analysis, Methodology, Software, Writing – Original Draft Preparation, Writing – Review & Editing

Edward G. Largo
Roles: Conceptualization, Resources, Supervision, Writing – Review & Editing

Maria Gogova
Roles: Conceptualization, Methodology, Resources, Supervision, Writing – Review & Editing

Competing interests

All authors are full-time employees of Altria Client Services LLC.

Grant information

The study is supported by Altria Client Services LLC.

Article Versions (3)

version 3

Revised

Published: 23 Jun 2020, 8:2099

https://doi.org/10.12688/f1000research.21377.3

version 2

Revised

Published: 04 May 2020, 8:2099

https://doi.org/10.12688/f1000research.21377.2

version 1

Published: 13 Dec 2019, 8:2099

https://doi.org/10.12688/f1000research.21377.1

© 2019 Cheng HG et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

SEE MORE DETAILS

CITE

how to cite this article

Cheng HG, Largo EG and Gogova M. E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the ‘common liability’ theory [version 1; peer review: 2 approved with reservations] F1000Research 2019, 8:2099 (https://doi.org/10.12688/f1000research.21377.1)

NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?

Key to Reviewer Statuses VIEW HIDE

ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Version 1

VERSION 1

PUBLISHED 13 Dec 2019

Views

Reviewer Report 28 Jan 2020

Alexa Gallagher, Ramboll, Amhurst, USA

Sandra I. Sulsky, Ramboll Environ US Corporation, Amherst, MA, USA

Approved with Reservations

https://doi.org/10.5256/f1000research.23544.r57841

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

Introduction

Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.
I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.
The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.
The discussion of ecological studies is lengthy and could be shortened.
Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Methods

SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.
The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?
Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.
The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.
Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?
Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Results

Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.
Also, please include a baseline table that provides basic demographic information. This could also be described in text.
The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.
In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.
I’d suggest placing the model results described in the text in a table.

Discussion

The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.
The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.
The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Thank you for the opportunity to be a reviewer of this study. It is my recommendation that this paper be approved with reservations.

Is the work clearly and accurately presented and does it cite the current literature?

Partly
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Partly
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Epidemiology

We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.

CITE

Report a concern

Author Response 04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

04 May 2020

Author Response

Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 ... Continue reading Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

1. Introduction

1.1 Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.

Authors response: We thank the reviewer for recognizing the value of the research question. We have amended the introduction to make it more focused based on reviewers’ helpful comments as follows.

1.2 I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.

Authors response: We have reorganized the discussion of existing literature in the revised manuscript. It now begins with observational studies, followed by the experimental study by Vasiljevic and colleagues, and then ecological evidence. The description of the Vasiljevic study has been shortened.

1.3 The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.

Authors response: We have added more details of reference #26 (now reference # 15) in the revised manuscript (the middle of the 5^th paragraph in the Introduction and the middle of the second paragraph in Discussion). During the revision, another study using similar method has been published. In this study, an inverse association was found between e-cigarette use and subsequent cigarette smoking using data from NYTS. We have added this study in the revised manuscript (ref. #16).

1.4 The discussion of ecological studies is lengthy and could be shortened.

Authors response: We have shortened the discussion about ecological studies in the revised manuscript.

1.5 Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Authors response: In the revised manuscript, we have added more details about the common liability theory (the beginning of the 5^th paragraph of the Introduction).

2. Methods

2.1 SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.

Authors response: We have added a brief introduction of SEM and why we think SEM is appropriate for this analysis based on the common liability theory (2^nd paragraph under Analysis Approach).

2.2 The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?

Authors response: PATH wave 3 data were not available when we started this project. During the course of the project, they became available. We did repeat the analysis using wave 2 and 3 data, and the results are similar. We have added estimates using wave 2 and 3 data in the Results section of the revised manuscript and in the new Table 3.
Nonetheless, we consider wave 1 and 2 data our primary focus because it is what we set out to do. Also, PATH wave 1 is the true baseline cohort, which is a representative sample of youth. Wave 2 is a follow-up of the wave 1 cohort with ‘shadow’ youth (those younger than 12) sampled at wave 1. In addition, for longitudinal studies like PATH, attrition occurs at each follow-up. When using wave 2 and 3 data, attrition may play a larger role.

2.3 Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.

Authors response: We did discuss whether we should include aged-up youth in the analysis, and we decided not to because the focus of this study is on youth smoking onset. During wave 1 and 2 data collection (2013-2015), cigarettes were legal for 18-year-olds to purchase in most places. Risk profiles and mechanisms may differ for underage smoking from of-age smoking. We wanted to retain a focus on youth smoking onset and, therefore, did not include 18 year olds in the current study.

2.4 The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.

Authors response: We have added a paragraph in the Method section to describe a series of models to explore the sensitivity of the main model results, including the model with additional psychosocial covariates and the model with wave 2 and wave 3 data, as suggested by the reviewers (fourth paragraph in the Analysis section).

2.5 Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?

Authors response: We have added additional covariates in the series of exploratory analysis described in the revised manuscript. Please see our response to reviewer #1’s comment #2 for a detailed explanation.

2.6 Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Authors response: We have added a sentence in the revised manuscript to indicate that for all tobacco use variables, there were <3% missing values. In addition, we specified a robust weighted least square mean and variance adjusted estimator which uses a full weight matrix. Therefore, a participant is included in the model unless the participant has missing values in all indicator variables (i.e., tobacco use and substance use variables). None of wave 1 never smokers had missing values in all of these variables, so we are able to include all never smokers in our model. We have added this information in the last paragraph of the Methods section in the revised manuscript.

3. Results

3.1 Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.

Authors response: In the revised manuscript, we added a sentence about the number of participants included in the current study:
Among 13,651 participants at wave 1, 11,792 were never smokers, among whom 9,045 remained youth (12-17 years of age) and were followed up for wave 2 assessment.
The sampling procedure of PATH is described in detail in PATH User’s Guide (ref. #39)

3.2 Also, please include a baseline table that provides basic demographic information. This could also be described in text.

Authors response: In the revised manuscript, we have added basic demographics of the sample in Table 1 and a sentence in the first paragraph of the Results section:
Of the 9,045 participants, 51% were males; 64% were 12-14 year olds; and 54% were non-Hispanic whites.

3.3 The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.

Authors response: We have adjusted the titles of Table 1 and Table 2 to reflect the estimates are among wave 1 never smokers.

3.4 In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.

Authors response: In the revised manuscript, we have combined the previous Table 1 and 2 into one table (new Table 1).

3.5 I’d suggest placing the model results described in the text in a table.

Authors response: We have added Table 2 which contains model results.

4. Discussion

4.1 The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.

Authors response: As we indicated above, we have added additional covariates in the model in our exploratory analyses, and the estimates were very similar to the one from the main model. We think these additional results suggest a certain degree of robustness of the latent ‘common liability’ construct and the main model overall. We have added this information and related discussion in the revised manuscript.
Please also see our response to comment 2.5 and to reviewer #1’s comment #2 for more details.

4.2 The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.

Authors response: Regarding concerns about other covariates, we have conducted additional exploratory analyses to incorporate additional covariates related to smoking onset based on previous literature. Please also see our response to comment 2.5 and to reviewer #1’s comment #2.
Regarding recall bias, we understand that the follow-up interval is only a year; however, there has been literature showing inconsistencies in the reporting of tobacco use as well as alcohol drinking behaviors in the youth population. In a cross-sectional setting, a smoker may be more likely to recall other tobacco use and vice versa because they can be correlated behaviors. Therefore, we think it is a noteworthy strength of the current study.

4.3 The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Authors response: We have revised both the Introduction and Discussion to provide fuller details of previous studies and their relevance to the current study to help put findings from the current study into context.

In closing, we thank all three reviewers for their helpful and constructive comments. We hope we have provided sufficient information and revision to make the work acceptable for publication.
Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

1. Introduction

1.1 Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.

Authors response: We thank the reviewer for recognizing the value of the research question. We have amended the introduction to make it more focused based on reviewers’ helpful comments as follows.

1.2 I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.

Authors response: We have reorganized the discussion of existing literature in the revised manuscript. It now begins with observational studies, followed by the experimental study by Vasiljevic and colleagues, and then ecological evidence. The description of the Vasiljevic study has been shortened.

1.3 The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.

Authors response: We have added more details of reference #26 (now reference # 15) in the revised manuscript (the middle of the 5^th paragraph in the Introduction and the middle of the second paragraph in Discussion). During the revision, another study using similar method has been published. In this study, an inverse association was found between e-cigarette use and subsequent cigarette smoking using data from NYTS. We have added this study in the revised manuscript (ref. #16).

1.4 The discussion of ecological studies is lengthy and could be shortened.

Authors response: We have shortened the discussion about ecological studies in the revised manuscript.

1.5 Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Authors response: In the revised manuscript, we have added more details about the common liability theory (the beginning of the 5^th paragraph of the Introduction).

2. Methods

2.1 SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.

Authors response: We have added a brief introduction of SEM and why we think SEM is appropriate for this analysis based on the common liability theory (2^nd paragraph under Analysis Approach).

2.2 The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?

Authors response: PATH wave 3 data were not available when we started this project. During the course of the project, they became available. We did repeat the analysis using wave 2 and 3 data, and the results are similar. We have added estimates using wave 2 and 3 data in the Results section of the revised manuscript and in the new Table 3.
Nonetheless, we consider wave 1 and 2 data our primary focus because it is what we set out to do. Also, PATH wave 1 is the true baseline cohort, which is a representative sample of youth. Wave 2 is a follow-up of the wave 1 cohort with ‘shadow’ youth (those younger than 12) sampled at wave 1. In addition, for longitudinal studies like PATH, attrition occurs at each follow-up. When using wave 2 and 3 data, attrition may play a larger role.

2.3 Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.

Authors response: We did discuss whether we should include aged-up youth in the analysis, and we decided not to because the focus of this study is on youth smoking onset. During wave 1 and 2 data collection (2013-2015), cigarettes were legal for 18-year-olds to purchase in most places. Risk profiles and mechanisms may differ for underage smoking from of-age smoking. We wanted to retain a focus on youth smoking onset and, therefore, did not include 18 year olds in the current study.

2.4 The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.

Authors response: We have added a paragraph in the Method section to describe a series of models to explore the sensitivity of the main model results, including the model with additional psychosocial covariates and the model with wave 2 and wave 3 data, as suggested by the reviewers (fourth paragraph in the Analysis section).

2.5 Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?

Authors response: We have added additional covariates in the series of exploratory analysis described in the revised manuscript. Please see our response to reviewer #1’s comment #2 for a detailed explanation.

2.6 Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Authors response: We have added a sentence in the revised manuscript to indicate that for all tobacco use variables, there were <3% missing values. In addition, we specified a robust weighted least square mean and variance adjusted estimator which uses a full weight matrix. Therefore, a participant is included in the model unless the participant has missing values in all indicator variables (i.e., tobacco use and substance use variables). None of wave 1 never smokers had missing values in all of these variables, so we are able to include all never smokers in our model. We have added this information in the last paragraph of the Methods section in the revised manuscript.

3. Results

3.1 Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.

Authors response: In the revised manuscript, we added a sentence about the number of participants included in the current study:
Among 13,651 participants at wave 1, 11,792 were never smokers, among whom 9,045 remained youth (12-17 years of age) and were followed up for wave 2 assessment.
The sampling procedure of PATH is described in detail in PATH User’s Guide (ref. #39)

3.2 Also, please include a baseline table that provides basic demographic information. This could also be described in text.

Authors response: In the revised manuscript, we have added basic demographics of the sample in Table 1 and a sentence in the first paragraph of the Results section:
Of the 9,045 participants, 51% were males; 64% were 12-14 year olds; and 54% were non-Hispanic whites.

3.3 The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.

Authors response: We have adjusted the titles of Table 1 and Table 2 to reflect the estimates are among wave 1 never smokers.

3.4 In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.

Authors response: In the revised manuscript, we have combined the previous Table 1 and 2 into one table (new Table 1).

3.5 I’d suggest placing the model results described in the text in a table.

Authors response: We have added Table 2 which contains model results.

4. Discussion

4.1 The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.

Authors response: As we indicated above, we have added additional covariates in the model in our exploratory analyses, and the estimates were very similar to the one from the main model. We think these additional results suggest a certain degree of robustness of the latent ‘common liability’ construct and the main model overall. We have added this information and related discussion in the revised manuscript.
Please also see our response to comment 2.5 and to reviewer #1’s comment #2 for more details.

4.2 The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.

Authors response: Regarding concerns about other covariates, we have conducted additional exploratory analyses to incorporate additional covariates related to smoking onset based on previous literature. Please also see our response to comment 2.5 and to reviewer #1’s comment #2.
Regarding recall bias, we understand that the follow-up interval is only a year; however, there has been literature showing inconsistencies in the reporting of tobacco use as well as alcohol drinking behaviors in the youth population. In a cross-sectional setting, a smoker may be more likely to recall other tobacco use and vice versa because they can be correlated behaviors. Therefore, we think it is a noteworthy strength of the current study.

4.3 The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Authors response: We have revised both the Introduction and Discussion to provide fuller details of previous studies and their relevance to the current study to help put findings from the current study into context.

In closing, we thank all three reviewers for their helpful and constructive comments. We hope we have provided sufficient information and revision to make the work acceptable for publication.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

04 May 2020

Author Response

Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 ... Continue reading Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

1. Introduction

1.1 Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.

Authors response: We thank the reviewer for recognizing the value of the research question. We have amended the introduction to make it more focused based on reviewers’ helpful comments as follows.

1.2 I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.

Authors response: We have reorganized the discussion of existing literature in the revised manuscript. It now begins with observational studies, followed by the experimental study by Vasiljevic and colleagues, and then ecological evidence. The description of the Vasiljevic study has been shortened.

1.3 The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.

Authors response: We have added more details of reference #26 (now reference # 15) in the revised manuscript (the middle of the 5^th paragraph in the Introduction and the middle of the second paragraph in Discussion). During the revision, another study using similar method has been published. In this study, an inverse association was found between e-cigarette use and subsequent cigarette smoking using data from NYTS. We have added this study in the revised manuscript (ref. #16).

1.4 The discussion of ecological studies is lengthy and could be shortened.

Authors response: We have shortened the discussion about ecological studies in the revised manuscript.

1.5 Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Authors response: In the revised manuscript, we have added more details about the common liability theory (the beginning of the 5^th paragraph of the Introduction).

2. Methods

2.1 SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.

Authors response: We have added a brief introduction of SEM and why we think SEM is appropriate for this analysis based on the common liability theory (2^nd paragraph under Analysis Approach).

2.2 The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?

Authors response: PATH wave 3 data were not available when we started this project. During the course of the project, they became available. We did repeat the analysis using wave 2 and 3 data, and the results are similar. We have added estimates using wave 2 and 3 data in the Results section of the revised manuscript and in the new Table 3.
Nonetheless, we consider wave 1 and 2 data our primary focus because it is what we set out to do. Also, PATH wave 1 is the true baseline cohort, which is a representative sample of youth. Wave 2 is a follow-up of the wave 1 cohort with ‘shadow’ youth (those younger than 12) sampled at wave 1. In addition, for longitudinal studies like PATH, attrition occurs at each follow-up. When using wave 2 and 3 data, attrition may play a larger role.

2.3 Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.

Authors response: We did discuss whether we should include aged-up youth in the analysis, and we decided not to because the focus of this study is on youth smoking onset. During wave 1 and 2 data collection (2013-2015), cigarettes were legal for 18-year-olds to purchase in most places. Risk profiles and mechanisms may differ for underage smoking from of-age smoking. We wanted to retain a focus on youth smoking onset and, therefore, did not include 18 year olds in the current study.

2.4 The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.

Authors response: We have added a paragraph in the Method section to describe a series of models to explore the sensitivity of the main model results, including the model with additional psychosocial covariates and the model with wave 2 and wave 3 data, as suggested by the reviewers (fourth paragraph in the Analysis section).

2.5 Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?

Authors response: We have added additional covariates in the series of exploratory analysis described in the revised manuscript. Please see our response to reviewer #1’s comment #2 for a detailed explanation.

2.6 Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Authors response: We have added a sentence in the revised manuscript to indicate that for all tobacco use variables, there were <3% missing values. In addition, we specified a robust weighted least square mean and variance adjusted estimator which uses a full weight matrix. Therefore, a participant is included in the model unless the participant has missing values in all indicator variables (i.e., tobacco use and substance use variables). None of wave 1 never smokers had missing values in all of these variables, so we are able to include all never smokers in our model. We have added this information in the last paragraph of the Methods section in the revised manuscript.

3. Results

3.1 Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.

Authors response: In the revised manuscript, we added a sentence about the number of participants included in the current study:
Among 13,651 participants at wave 1, 11,792 were never smokers, among whom 9,045 remained youth (12-17 years of age) and were followed up for wave 2 assessment.
The sampling procedure of PATH is described in detail in PATH User’s Guide (ref. #39)

3.2 Also, please include a baseline table that provides basic demographic information. This could also be described in text.

Authors response: In the revised manuscript, we have added basic demographics of the sample in Table 1 and a sentence in the first paragraph of the Results section:
Of the 9,045 participants, 51% were males; 64% were 12-14 year olds; and 54% were non-Hispanic whites.

3.3 The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.

Authors response: We have adjusted the titles of Table 1 and Table 2 to reflect the estimates are among wave 1 never smokers.

3.4 In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.

Authors response: In the revised manuscript, we have combined the previous Table 1 and 2 into one table (new Table 1).

3.5 I’d suggest placing the model results described in the text in a table.

Authors response: We have added Table 2 which contains model results.

4. Discussion

4.1 The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.

Authors response: As we indicated above, we have added additional covariates in the model in our exploratory analyses, and the estimates were very similar to the one from the main model. We think these additional results suggest a certain degree of robustness of the latent ‘common liability’ construct and the main model overall. We have added this information and related discussion in the revised manuscript.
Please also see our response to comment 2.5 and to reviewer #1’s comment #2 for more details.

4.2 The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.

Authors response: Regarding concerns about other covariates, we have conducted additional exploratory analyses to incorporate additional covariates related to smoking onset based on previous literature. Please also see our response to comment 2.5 and to reviewer #1’s comment #2.
Regarding recall bias, we understand that the follow-up interval is only a year; however, there has been literature showing inconsistencies in the reporting of tobacco use as well as alcohol drinking behaviors in the youth population. In a cross-sectional setting, a smoker may be more likely to recall other tobacco use and vice versa because they can be correlated behaviors. Therefore, we think it is a noteworthy strength of the current study.

4.3 The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Authors response: We have revised both the Introduction and Discussion to provide fuller details of previous studies and their relevance to the current study to help put findings from the current study into context.

In closing, we thank all three reviewers for their helpful and constructive comments. We hope we have provided sufficient information and revision to make the work acceptable for publication.
Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

1. Introduction

1.1 Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.

Authors response: We thank the reviewer for recognizing the value of the research question. We have amended the introduction to make it more focused based on reviewers’ helpful comments as follows.

1.2 I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.

Authors response: We have reorganized the discussion of existing literature in the revised manuscript. It now begins with observational studies, followed by the experimental study by Vasiljevic and colleagues, and then ecological evidence. The description of the Vasiljevic study has been shortened.

1.3 The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.

Authors response: We have added more details of reference #26 (now reference # 15) in the revised manuscript (the middle of the 5^th paragraph in the Introduction and the middle of the second paragraph in Discussion). During the revision, another study using similar method has been published. In this study, an inverse association was found between e-cigarette use and subsequent cigarette smoking using data from NYTS. We have added this study in the revised manuscript (ref. #16).

1.4 The discussion of ecological studies is lengthy and could be shortened.

Authors response: We have shortened the discussion about ecological studies in the revised manuscript.

1.5 Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Authors response: In the revised manuscript, we have added more details about the common liability theory (the beginning of the 5^th paragraph of the Introduction).

2. Methods

2.1 SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.

Authors response: We have added a brief introduction of SEM and why we think SEM is appropriate for this analysis based on the common liability theory (2^nd paragraph under Analysis Approach).

2.2 The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?

Authors response: PATH wave 3 data were not available when we started this project. During the course of the project, they became available. We did repeat the analysis using wave 2 and 3 data, and the results are similar. We have added estimates using wave 2 and 3 data in the Results section of the revised manuscript and in the new Table 3.
Nonetheless, we consider wave 1 and 2 data our primary focus because it is what we set out to do. Also, PATH wave 1 is the true baseline cohort, which is a representative sample of youth. Wave 2 is a follow-up of the wave 1 cohort with ‘shadow’ youth (those younger than 12) sampled at wave 1. In addition, for longitudinal studies like PATH, attrition occurs at each follow-up. When using wave 2 and 3 data, attrition may play a larger role.

2.3 Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.

Authors response: We did discuss whether we should include aged-up youth in the analysis, and we decided not to because the focus of this study is on youth smoking onset. During wave 1 and 2 data collection (2013-2015), cigarettes were legal for 18-year-olds to purchase in most places. Risk profiles and mechanisms may differ for underage smoking from of-age smoking. We wanted to retain a focus on youth smoking onset and, therefore, did not include 18 year olds in the current study.

2.4 The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.

Authors response: We have added a paragraph in the Method section to describe a series of models to explore the sensitivity of the main model results, including the model with additional psychosocial covariates and the model with wave 2 and wave 3 data, as suggested by the reviewers (fourth paragraph in the Analysis section).

2.5 Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?

Authors response: We have added additional covariates in the series of exploratory analysis described in the revised manuscript. Please see our response to reviewer #1’s comment #2 for a detailed explanation.

2.6 Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Authors response: We have added a sentence in the revised manuscript to indicate that for all tobacco use variables, there were <3% missing values. In addition, we specified a robust weighted least square mean and variance adjusted estimator which uses a full weight matrix. Therefore, a participant is included in the model unless the participant has missing values in all indicator variables (i.e., tobacco use and substance use variables). None of wave 1 never smokers had missing values in all of these variables, so we are able to include all never smokers in our model. We have added this information in the last paragraph of the Methods section in the revised manuscript.

3. Results

3.1 Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.

Authors response: In the revised manuscript, we added a sentence about the number of participants included in the current study:
Among 13,651 participants at wave 1, 11,792 were never smokers, among whom 9,045 remained youth (12-17 years of age) and were followed up for wave 2 assessment.
The sampling procedure of PATH is described in detail in PATH User’s Guide (ref. #39)

3.2 Also, please include a baseline table that provides basic demographic information. This could also be described in text.

Authors response: In the revised manuscript, we have added basic demographics of the sample in Table 1 and a sentence in the first paragraph of the Results section:
Of the 9,045 participants, 51% were males; 64% were 12-14 year olds; and 54% were non-Hispanic whites.

3.3 The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.

Authors response: We have adjusted the titles of Table 1 and Table 2 to reflect the estimates are among wave 1 never smokers.

3.4 In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.

Authors response: In the revised manuscript, we have combined the previous Table 1 and 2 into one table (new Table 1).

3.5 I’d suggest placing the model results described in the text in a table.

Authors response: We have added Table 2 which contains model results.

4. Discussion

4.1 The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.

Authors response: As we indicated above, we have added additional covariates in the model in our exploratory analyses, and the estimates were very similar to the one from the main model. We think these additional results suggest a certain degree of robustness of the latent ‘common liability’ construct and the main model overall. We have added this information and related discussion in the revised manuscript.
Please also see our response to comment 2.5 and to reviewer #1’s comment #2 for more details.

4.2 The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.

Authors response: Regarding concerns about other covariates, we have conducted additional exploratory analyses to incorporate additional covariates related to smoking onset based on previous literature. Please also see our response to comment 2.5 and to reviewer #1’s comment #2.
Regarding recall bias, we understand that the follow-up interval is only a year; however, there has been literature showing inconsistencies in the reporting of tobacco use as well as alcohol drinking behaviors in the youth population. In a cross-sectional setting, a smoker may be more likely to recall other tobacco use and vice versa because they can be correlated behaviors. Therefore, we think it is a noteworthy strength of the current study.

4.3 The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Authors response: We have revised both the Introduction and Discussion to provide fuller details of previous studies and their relevance to the current study to help put findings from the current study into context.

In closing, we thank all three reviewers for their helpful and constructive comments. We hope we have provided sufficient information and revision to make the work acceptable for publication.
Competing Interests: No competing interests were disclosed. Close
Report a concern

Views

Reviewer Report 08 Jan 2020

Arielle S. Selya, Behavioral Sciences Group, Sanford Research, Sioux Falls, USA; Pinney Associates, Inc., Pittsburgh, PA, USA

Approved with Reservations

https://doi.org/10.5256/f1000research.23544.r57839

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important.

Major comments:

The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.
My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?
I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Minor comments:

I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.
On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?
What does the acronym ACASI mean (p.7)?

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Behavioral science, esp. nicotine use and dependence among adolescents

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Author Response 04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

04 May 2020

Author Response
Dr. Selya’s comments

General comments:
- This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both
... Continue reading
Dr. Selya’s comments

General comments:

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important. Authors response: We thank the reviewer for recognizing the significance and novelty of the work and the helpful comments. We have revised the original manuscript based on these comments as detailed below.

Major comments:

1. The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.

Authors response: We thank the reviewer for recognizing the value of the research question.

2. My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?

Authors response: We agree with the reviewer that the propensity to use tobacco products is multifaceted, including important factors mentioned by the reviewers.
In this study, we were guided by the ‘common-liability’ theory and hypothesized that the use of various tobacco products is driven by an unobserved latent liability to use tobacco products. That is, a single-dimension latent variable (i.e., the liability to use tobacco products) gives rise to the use of different tobacco products. This latent liability to use tobacco products likely varies by socioeconomic, personality characteristics, risk perception, peer influence, and familial history of substance use, mental health etc., which can be precedents, consequences, or both (feedback loops) of tobacco use. That is, our expectation is that the latent variable, which represents an individual’s liability to use tobacco products, is correlated with these other variables. Practically, one complexity to include various other factors in the structural equation framework is that these variables are not necessarily manifestations of a single dimension, which complicates the structure of the measurement model. Due to the above theoretical and practical reasons, we chose to take a simpler theory-driven approach to define the latent construct by tobacco use behaviors and only included sex and age as covariates because they are exogenous to the liability-and-smoking-onset relationship. In an exploratory step, we further expanded the model to include other substances because it has been shown that adolescent substance use is highly opportunistic and tobacco use is highly correlated with other substance use among adolescents in the original submission.
That said, the reviewer’s concern is well taken. We have expanded the model to include aforementioned variables as covariates to the extent that they were assessed in PATH wave 1 survey. Specifically, we took a two-step approach to include additional covariates. First, we added race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanics, and non-Hispanic others), availability of tobacco products in the household (yes/no), and a measure of novelty seeking (“agree” or “strongly agree” to the question “I like new and exciting experiences, even if I have to break the rules. Do you…”). In the second step, we additionally included participant’s self-rated health (excellent/non-excellent), harm perception of cigarettes (“a lot of harm” to the question “How much do you think people harm themselves when they smoke cigarettes”), and participant’s grade (mostly A’s or A’s and B’s vs. others) because these variables are more likely to have feedback loops with tobacco use. These covariates were modeled to correlate with the latent liability construct and to predict the onset of cigarette smoking at wave 2.
The inclusion of these variables induced little change in estimates, although the latent-liability-to-smoking-onset path became marginally significant statistically, possibly due to the loss of precision associated with the additional covariates. Nonetheless, e-cigarette did not predict smoking onset in either model (Additional model 1: β=0.16; 95% CI= -0.04, 0.35; p=0.109; Additional model 2: β=0.16; 95% CI= -0.03, 0.35; p=0.102), and the latent liability of tobacco use predicted smoking onset in the first additional model (β=0.31; 95% CI= 0.01, 0.61; p=0.047) as well as in additional model 2 (β=0.31; 95% CI= 0.01, 0.61; p=0.047).
We observed little change in estimates for the e-cigarette-to-smoking relationship as well as the liability-to-smoking relationship across the four models (no covariates, sex-and-age as covariates, additional model 1, and additional model 2 described above), which suggests that the model is robust to variations of covariates.
In the revised manuscript, we have added this additional information in the Results section and revised the Discussion section accordingly.

3. I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Authors response: We thank the reviewer for the suggestion. We have moved the ‘Limitation and strengths’ section to the end of the manuscript.

Minor comments:

1. I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.

Authors response: We thank the reviewer for bringing it to our attention. After further consideration, we think the unstandardized thresholds are more meaningful than the standardized threshold. In the revised version, we have changed the standardized thresholds to unstandardized thresholds, which represents the ‘difficulty parameter’ of items. We have also added the following footnote for “standardized loading” in Table 1:
“Factor loadings are standardized based on the variances of the continuous latent variables as well as the variances of the outcome variables.”

2. On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?

Authors response: In the revised version, we have added exact values for these fit indices in the revised version as follows,
“RSMEA=0.015, 90% CI=0.012, 0.017; CFI=0.948, TLI=0.938 for the model without sex and age; RSMEA=0.016, 90% CI=0.015, 0.018; CFI=0.922, TLI=0.905 for the model out sex and age as covariates”
We did not report the exact values in the previous version because we considered the expanded model a post-estimation exploratory step and the results are similar to those of the main model.

3. What does the acronym ACASI mean (p.7)?

Authors response: ACASI stands for audio computer assisted self-interviews. It was defined at first appearance under “Assessment.” Since it only appeared three times in the manuscript, we have replaced the acronyms with its full name in the revised version.
Dr. Selya’s comments

General comments:

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important. Authors response: We thank the reviewer for recognizing the significance and novelty of the work and the helpful comments. We have revised the original manuscript based on these comments as detailed below.

Major comments:

1. The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.

Authors response: We thank the reviewer for recognizing the value of the research question.

2. My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?

Authors response: We agree with the reviewer that the propensity to use tobacco products is multifaceted, including important factors mentioned by the reviewers.
In this study, we were guided by the ‘common-liability’ theory and hypothesized that the use of various tobacco products is driven by an unobserved latent liability to use tobacco products. That is, a single-dimension latent variable (i.e., the liability to use tobacco products) gives rise to the use of different tobacco products. This latent liability to use tobacco products likely varies by socioeconomic, personality characteristics, risk perception, peer influence, and familial history of substance use, mental health etc., which can be precedents, consequences, or both (feedback loops) of tobacco use. That is, our expectation is that the latent variable, which represents an individual’s liability to use tobacco products, is correlated with these other variables. Practically, one complexity to include various other factors in the structural equation framework is that these variables are not necessarily manifestations of a single dimension, which complicates the structure of the measurement model. Due to the above theoretical and practical reasons, we chose to take a simpler theory-driven approach to define the latent construct by tobacco use behaviors and only included sex and age as covariates because they are exogenous to the liability-and-smoking-onset relationship. In an exploratory step, we further expanded the model to include other substances because it has been shown that adolescent substance use is highly opportunistic and tobacco use is highly correlated with other substance use among adolescents in the original submission.
That said, the reviewer’s concern is well taken. We have expanded the model to include aforementioned variables as covariates to the extent that they were assessed in PATH wave 1 survey. Specifically, we took a two-step approach to include additional covariates. First, we added race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanics, and non-Hispanic others), availability of tobacco products in the household (yes/no), and a measure of novelty seeking (“agree” or “strongly agree” to the question “I like new and exciting experiences, even if I have to break the rules. Do you…”). In the second step, we additionally included participant’s self-rated health (excellent/non-excellent), harm perception of cigarettes (“a lot of harm” to the question “How much do you think people harm themselves when they smoke cigarettes”), and participant’s grade (mostly A’s or A’s and B’s vs. others) because these variables are more likely to have feedback loops with tobacco use. These covariates were modeled to correlate with the latent liability construct and to predict the onset of cigarette smoking at wave 2.
The inclusion of these variables induced little change in estimates, although the latent-liability-to-smoking-onset path became marginally significant statistically, possibly due to the loss of precision associated with the additional covariates. Nonetheless, e-cigarette did not predict smoking onset in either model (Additional model 1: β=0.16; 95% CI= -0.04, 0.35; p=0.109; Additional model 2: β=0.16; 95% CI= -0.03, 0.35; p=0.102), and the latent liability of tobacco use predicted smoking onset in the first additional model (β=0.31; 95% CI= 0.01, 0.61; p=0.047) as well as in additional model 2 (β=0.31; 95% CI= 0.01, 0.61; p=0.047).
We observed little change in estimates for the e-cigarette-to-smoking relationship as well as the liability-to-smoking relationship across the four models (no covariates, sex-and-age as covariates, additional model 1, and additional model 2 described above), which suggests that the model is robust to variations of covariates.
In the revised manuscript, we have added this additional information in the Results section and revised the Discussion section accordingly.

3. I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Authors response: We thank the reviewer for the suggestion. We have moved the ‘Limitation and strengths’ section to the end of the manuscript.

Minor comments:

1. I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.

Authors response: We thank the reviewer for bringing it to our attention. After further consideration, we think the unstandardized thresholds are more meaningful than the standardized threshold. In the revised version, we have changed the standardized thresholds to unstandardized thresholds, which represents the ‘difficulty parameter’ of items. We have also added the following footnote for “standardized loading” in Table 1:
“Factor loadings are standardized based on the variances of the continuous latent variables as well as the variances of the outcome variables.”

2. On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?

Authors response: In the revised version, we have added exact values for these fit indices in the revised version as follows,
“RSMEA=0.015, 90% CI=0.012, 0.017; CFI=0.948, TLI=0.938 for the model without sex and age; RSMEA=0.016, 90% CI=0.015, 0.018; CFI=0.922, TLI=0.905 for the model out sex and age as covariates”
We did not report the exact values in the previous version because we considered the expanded model a post-estimation exploratory step and the results are similar to those of the main model.

3. What does the acronym ACASI mean (p.7)?

Authors response: ACASI stands for audio computer assisted self-interviews. It was defined at first appearance under “Assessment.” Since it only appeared three times in the manuscript, we have replaced the acronyms with its full name in the revised version.
Competing Interests: No competing interests were disclosed. Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

04 May 2020

Author Response
Dr. Selya’s comments

General comments:
- This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both
... Continue reading
Dr. Selya’s comments

General comments:

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important. Authors response: We thank the reviewer for recognizing the significance and novelty of the work and the helpful comments. We have revised the original manuscript based on these comments as detailed below.

Major comments:

1. The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.

Authors response: We thank the reviewer for recognizing the value of the research question.

2. My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?

Authors response: We agree with the reviewer that the propensity to use tobacco products is multifaceted, including important factors mentioned by the reviewers.
In this study, we were guided by the ‘common-liability’ theory and hypothesized that the use of various tobacco products is driven by an unobserved latent liability to use tobacco products. That is, a single-dimension latent variable (i.e., the liability to use tobacco products) gives rise to the use of different tobacco products. This latent liability to use tobacco products likely varies by socioeconomic, personality characteristics, risk perception, peer influence, and familial history of substance use, mental health etc., which can be precedents, consequences, or both (feedback loops) of tobacco use. That is, our expectation is that the latent variable, which represents an individual’s liability to use tobacco products, is correlated with these other variables. Practically, one complexity to include various other factors in the structural equation framework is that these variables are not necessarily manifestations of a single dimension, which complicates the structure of the measurement model. Due to the above theoretical and practical reasons, we chose to take a simpler theory-driven approach to define the latent construct by tobacco use behaviors and only included sex and age as covariates because they are exogenous to the liability-and-smoking-onset relationship. In an exploratory step, we further expanded the model to include other substances because it has been shown that adolescent substance use is highly opportunistic and tobacco use is highly correlated with other substance use among adolescents in the original submission.
That said, the reviewer’s concern is well taken. We have expanded the model to include aforementioned variables as covariates to the extent that they were assessed in PATH wave 1 survey. Specifically, we took a two-step approach to include additional covariates. First, we added race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanics, and non-Hispanic others), availability of tobacco products in the household (yes/no), and a measure of novelty seeking (“agree” or “strongly agree” to the question “I like new and exciting experiences, even if I have to break the rules. Do you…”). In the second step, we additionally included participant’s self-rated health (excellent/non-excellent), harm perception of cigarettes (“a lot of harm” to the question “How much do you think people harm themselves when they smoke cigarettes”), and participant’s grade (mostly A’s or A’s and B’s vs. others) because these variables are more likely to have feedback loops with tobacco use. These covariates were modeled to correlate with the latent liability construct and to predict the onset of cigarette smoking at wave 2.
The inclusion of these variables induced little change in estimates, although the latent-liability-to-smoking-onset path became marginally significant statistically, possibly due to the loss of precision associated with the additional covariates. Nonetheless, e-cigarette did not predict smoking onset in either model (Additional model 1: β=0.16; 95% CI= -0.04, 0.35; p=0.109; Additional model 2: β=0.16; 95% CI= -0.03, 0.35; p=0.102), and the latent liability of tobacco use predicted smoking onset in the first additional model (β=0.31; 95% CI= 0.01, 0.61; p=0.047) as well as in additional model 2 (β=0.31; 95% CI= 0.01, 0.61; p=0.047).
We observed little change in estimates for the e-cigarette-to-smoking relationship as well as the liability-to-smoking relationship across the four models (no covariates, sex-and-age as covariates, additional model 1, and additional model 2 described above), which suggests that the model is robust to variations of covariates.
In the revised manuscript, we have added this additional information in the Results section and revised the Discussion section accordingly.

3. I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Authors response: We thank the reviewer for the suggestion. We have moved the ‘Limitation and strengths’ section to the end of the manuscript.

Minor comments:

1. I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.

Authors response: We thank the reviewer for bringing it to our attention. After further consideration, we think the unstandardized thresholds are more meaningful than the standardized threshold. In the revised version, we have changed the standardized thresholds to unstandardized thresholds, which represents the ‘difficulty parameter’ of items. We have also added the following footnote for “standardized loading” in Table 1:
“Factor loadings are standardized based on the variances of the continuous latent variables as well as the variances of the outcome variables.”

2. On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?

Authors response: In the revised version, we have added exact values for these fit indices in the revised version as follows,
“RSMEA=0.015, 90% CI=0.012, 0.017; CFI=0.948, TLI=0.938 for the model without sex and age; RSMEA=0.016, 90% CI=0.015, 0.018; CFI=0.922, TLI=0.905 for the model out sex and age as covariates”
We did not report the exact values in the previous version because we considered the expanded model a post-estimation exploratory step and the results are similar to those of the main model.

3. What does the acronym ACASI mean (p.7)?

Authors response: ACASI stands for audio computer assisted self-interviews. It was defined at first appearance under “Assessment.” Since it only appeared three times in the manuscript, we have replaced the acronyms with its full name in the revised version.
Dr. Selya’s comments

General comments:

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important. Authors response: We thank the reviewer for recognizing the significance and novelty of the work and the helpful comments. We have revised the original manuscript based on these comments as detailed below.

Major comments:

1. The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.

Authors response: We thank the reviewer for recognizing the value of the research question.

2. My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?

Authors response: We agree with the reviewer that the propensity to use tobacco products is multifaceted, including important factors mentioned by the reviewers.
In this study, we were guided by the ‘common-liability’ theory and hypothesized that the use of various tobacco products is driven by an unobserved latent liability to use tobacco products. That is, a single-dimension latent variable (i.e., the liability to use tobacco products) gives rise to the use of different tobacco products. This latent liability to use tobacco products likely varies by socioeconomic, personality characteristics, risk perception, peer influence, and familial history of substance use, mental health etc., which can be precedents, consequences, or both (feedback loops) of tobacco use. That is, our expectation is that the latent variable, which represents an individual’s liability to use tobacco products, is correlated with these other variables. Practically, one complexity to include various other factors in the structural equation framework is that these variables are not necessarily manifestations of a single dimension, which complicates the structure of the measurement model. Due to the above theoretical and practical reasons, we chose to take a simpler theory-driven approach to define the latent construct by tobacco use behaviors and only included sex and age as covariates because they are exogenous to the liability-and-smoking-onset relationship. In an exploratory step, we further expanded the model to include other substances because it has been shown that adolescent substance use is highly opportunistic and tobacco use is highly correlated with other substance use among adolescents in the original submission.
That said, the reviewer’s concern is well taken. We have expanded the model to include aforementioned variables as covariates to the extent that they were assessed in PATH wave 1 survey. Specifically, we took a two-step approach to include additional covariates. First, we added race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanics, and non-Hispanic others), availability of tobacco products in the household (yes/no), and a measure of novelty seeking (“agree” or “strongly agree” to the question “I like new and exciting experiences, even if I have to break the rules. Do you…”). In the second step, we additionally included participant’s self-rated health (excellent/non-excellent), harm perception of cigarettes (“a lot of harm” to the question “How much do you think people harm themselves when they smoke cigarettes”), and participant’s grade (mostly A’s or A’s and B’s vs. others) because these variables are more likely to have feedback loops with tobacco use. These covariates were modeled to correlate with the latent liability construct and to predict the onset of cigarette smoking at wave 2.
The inclusion of these variables induced little change in estimates, although the latent-liability-to-smoking-onset path became marginally significant statistically, possibly due to the loss of precision associated with the additional covariates. Nonetheless, e-cigarette did not predict smoking onset in either model (Additional model 1: β=0.16; 95% CI= -0.04, 0.35; p=0.109; Additional model 2: β=0.16; 95% CI= -0.03, 0.35; p=0.102), and the latent liability of tobacco use predicted smoking onset in the first additional model (β=0.31; 95% CI= 0.01, 0.61; p=0.047) as well as in additional model 2 (β=0.31; 95% CI= 0.01, 0.61; p=0.047).
We observed little change in estimates for the e-cigarette-to-smoking relationship as well as the liability-to-smoking relationship across the four models (no covariates, sex-and-age as covariates, additional model 1, and additional model 2 described above), which suggests that the model is robust to variations of covariates.
In the revised manuscript, we have added this additional information in the Results section and revised the Discussion section accordingly.

3. I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Authors response: We thank the reviewer for the suggestion. We have moved the ‘Limitation and strengths’ section to the end of the manuscript.

Minor comments:

1. I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.

Authors response: We thank the reviewer for bringing it to our attention. After further consideration, we think the unstandardized thresholds are more meaningful than the standardized threshold. In the revised version, we have changed the standardized thresholds to unstandardized thresholds, which represents the ‘difficulty parameter’ of items. We have also added the following footnote for “standardized loading” in Table 1:
“Factor loadings are standardized based on the variances of the continuous latent variables as well as the variances of the outcome variables.”

2. On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?

Authors response: In the revised version, we have added exact values for these fit indices in the revised version as follows,
“RSMEA=0.015, 90% CI=0.012, 0.017; CFI=0.948, TLI=0.938 for the model without sex and age; RSMEA=0.016, 90% CI=0.015, 0.018; CFI=0.922, TLI=0.905 for the model out sex and age as covariates”
We did not report the exact values in the previous version because we considered the expanded model a post-estimation exploratory step and the results are similar to those of the main model.

3. What does the acronym ACASI mean (p.7)?

Authors response: ACASI stands for audio computer assisted self-interviews. It was defined at first appearance under “Assessment.” Since it only appeared three times in the manuscript, we have replaced the acronyms with its full name in the revised version.
Competing Interests: No competing interests were disclosed. Close
Report a concern

Comments on this article Comments (0)

Version 3

VERSION 3 PUBLISHED 13 Dec 2019

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2
Version 3 (revision) 23 Jun 20	read
Version 2 (revision) 04 May 20	read	read
Version 1 13 Dec 19	read	read

Arielle S. Selya, Sanford Research, Sioux Falls, USA; Pinney Associates, Inc., Pittsburgh, USA
Alexa Gallagher, Ramboll, Amhurst, USA

Sandra I. Sulsky, Ramboll Environ US Corporation, Amherst, USA

Comments on this article

All Comments(0)

Add a comment

Browse by related subjects

Back to all reports

Reviewer Report

13 Views

16 Jul 2020 | for Version 3

Arielle S. Selya, Behavioral Sciences Group, Sanford Research, Sioux Falls, USA; Pinney Associates, Inc., Pittsburgh, PA, USA

13 Views Cite this report Responses(0)

Approved

The authors have addressed all of my concerns.

Competing Interests

After my second review of this manuscript, I became employed by Pinney Associates, which provides consulting services on tobacco harm minimization to JUUL Labs, Inc. I performed the first two reviews of this manuscript prior to starting this employment relationship.

Reviewer Expertise

Behavioral science, esp. nicotine use and dependence among adolescents

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

19 Views

02 Jun 2020 | for Version 2

Alexa Gallagher, Ramboll, Amhurst, USA

Sandra I. Sulsky, Ramboll Environ US Corporation, Amherst, MA, USA

19 Views Cite this report Responses(1)

Approved

We were pleased to review the revised version of the Cheng et al. (2019) manuscript. The authors made several changes that strengthened and clarified the manuscript including a re-organization of the introduction with additional information on Kim et al. (2019) and a very recently published study by Shahab et al. (2020) and an explanation of the common liability theory. The methods section now includes more background information on SEM, which will be helpful to readers not familiar with this type of modeling. We were also pleased to see sensitivity analyses using PATH Wave 3 data as well as analyses including a broader set of covariates (age, sex, race/ethnicity, tobacco product availability in the household, novelty seeking, self-rated health, cigarette smoking harm perception, school performance). The authors provided detail about how missing information was handled. The results section now includes some basic demographic information, revisions to the tables, and additional results based on the new sensitivity analyses described in the methods.

We have a few minor suggestions:

On page 5, the first letter of the first complete paragraph needs to be capitalized.

Table 2 provides results for models M1 to M6 using PATH waves 1 and 2 data. The written results describe models M1 and M2 followed by M5 and M6. Models M3 and M4 are described last. Why not change the order of the models in the table so they are described in sequence in the results?

Please revisit the title of table 2. You present estimates for e-cigarette use and onset of ever cigarette smoking as well as estimates for the liability to use tobacco and the onset of ever cigarette smoking. The title only explains the e-cigarette piece.

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Epidemiology

We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (1)

Author Response

23 Jun 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

We are delighted to see that reviewers are happy about the revision. We appreciate reviewers’ constructive comments which have helped us improve the manuscript.
We have made additional adjustments based on reviewers' comments. Specifically, we have changed the model labels, and we have changed the title of Table 2 to “Estimated relationships linking e-cigarette use and common liability latent construct to onset of ever cigarette smoking from structural equation models. Data from Population Assessment of Tobacco and Health survey”.

View more View less

Competing Interests

No competing interests were disclosed.

Back to all reports

Reviewer Report

23 Views

26 May 2020 | for Version 2

Arielle S. Selya, Behavioral Sciences Group, Sanford Research, Sioux Falls, USA; Pinney Associates, Inc., Pittsburgh, PA, USA

23 Views Cite this report Responses(1)

Approved With Reservations

The authors have done an excellent job responding to my concerns. I agree that a latent factor for nicotine use would make sense as a single latent factor, and that additional covariates would add complications. However, the additional exploratory analyses which include such covariates show that the findings are robust. I have a few remaining comments:

My biggest concern is that the authors should be careful not to conclude *no relationship* between e-cigarettes and later cigarette use. Using the significance testing here, that cannot be concluded. A couple specific points:
- Such results should be worded as, e.g. “not significantly associated with” instead of “not associated with” (p. 6).
- Though the Beta coefficient does not reach statistical significance, it does look like it’s trending towards a small but positive value (~0.13) based on most of the confidence interval being above 0. It is possible then, that with larger sample sizes, this could become significant.
- Therefore it might be helpful to also phrase this as, “common liability is sufficient to explain later cigarette use” if this is backed up by your results.
- In this vein, it might be valuable to do something like a nested model test of M1 vs. a model where the path from e-cigarettes to later cigarette use is removed; if the model fit does not substantially worsen, then this would support e-cigarettes not having any additional explanatory power in addition to that of the latent factor.
- An inconsistency with respect to how p-values are treated: in one place, p=.054 is interpreted as “not statistically significant”; but in another place, p=.074 is interpreted as “marginally associated.” This highlights the importance of interpreting the effect sizes as well (e.g. Beta coefficients).
It would be more appropriate to use “nicotine” rather than “tobacco” in most instances, as e-cigarettes contain nicotine but not tobacco.
Another recent paper may be relevant in the literature review on common liability: Foxon & Selya, 2020, Addiction¹, which shows that total nicotine use trends (i.e. the use of any nicotine product) has not changed after the introduction of e-cigarettes.

References

1. Foxon F, Selya A: Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 2018. Addiction. 2020. Publisher Full Text

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Behavioral science, esp. nicotine use and dependence among adolescents

Respond to this report

Responses (1)

Author Response

23 Jun 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

We thank the reviewer for the positive response. We have amended the manuscript based on reviewer's comments.
To address the reviewer's comment about non-significant relationships, we have made the following revisions to the manuscript: (1) we have changed description of null associations to “not statistically significant…”; (2) we have changed the first sentence in the Discussion section to “In this study, we found that the latent ‘common liability to use nicotine products’ construct is sufficient to explain later onset of smoking among US adolescents.”; (3) we have used consistent description for p-values and highlighted the importance of the beta coefficients (last paragraph of Results) and; (4) we have added the following language in the Discussion section “In this study, we observed a much smaller point estimates for the e-cigarette-to-smoking relationship compared to estimates for the common-liability-to-smoking relationship. Together with the fairly large sample size of PATH (which grants reasonable statistical power), it suggests that the “common liability to nicotine use” is sufficient to explain the onset of cigarette smoking among adolescents.”

We agree with the reviewer that a test of nested models would help make the point that the e-cigarette-to-cigarette path does not substantially improve the model fit. Regrettably, the use of replicate weights (to properly calculate the variance) precludes such formal comparisons of model fit. Nonetheless, as we mentioned above, we have added language emphasizing the effect size estimates.

With respect to the reviewer's comment about using 'nicotine' instead of 'tobacco,' we thank the reviewer for pointing it out. The point is well taken. Nonetheless, we decided to retain the term 'tobacco products' for the following reasons: (1) although e-cigarettes do not contain natural tobacco, they typically contain tobacco-derived nicotine; (2) the FDA has deemed and regulates e-cigarettes as tobacco products, (3) other nicotine products (e.g., nicotine replacement therapy or novel oral tobacco-derived nicotine products) are not included in this study. We hope these reasons are sufficient to justify our use of ‘tobacco’ products in this manuscript.

We thank the reviewer to bring the recent paper to our attention. We have cited the paper in the Introduction section of the revised manuscript (reference #20).

View more View less

Competing Interests

No competing interests were disclosed.

Back to all reports

Reviewer Report

20 Views

28 Jan 2020 | for Version 1

Alexa Gallagher, Ramboll, Amhurst, USA

Sandra I. Sulsky, Ramboll Environ US Corporation, Amherst, MA, USA

20 Views Cite this report Responses(1)

Approved With Reservations

Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.
I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.
The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.
The discussion of ecological studies is lengthy and could be shortened.
Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Methods

SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.
The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?
Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.
The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.
Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?
Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Results

Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.
Also, please include a baseline table that provides basic demographic information. This could also be described in text.
The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.
In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.
I’d suggest placing the model results described in the text in a table.

Discussion

The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.
The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.
The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Thank you for the opportunity to be a reviewer of this study. It is my recommendation that this paper be approved with reservations.

Is the work clearly and accurately presented and does it cite the current literature?

Partly
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Partly
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Epidemiology

Respond to this report

Responses (1)

Author Response

04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

Dr. Gallagher and Dr. Sulsky comments

Cheng et al. (2019) examines the association between e-cigarette use and onset of cigarette smoking in youth between the ages of 12 and 17 years in the U.S. They utilize nationally representative and publicly available data from the PATH study. The research was guided by “common liability” theory, which “postulates that any observed relationship between e-cigarettes and combustible tobacco products is attributed to the liability to use tobacco products of the individual; once this common liability is controlled for, there is no causal relationship between e-cigarette use and cigarette smoking.” The authors report that they are the first study to use structural equation modeling to answer this question.

1. Introduction

1.1 Cheng and colleagues ask an interesting and timely research question. They include a series of recent publications in their background as they lay out their justification. The introduction, however, is rather long and somewhat unfocused.

Authors response: We thank the reviewer for recognizing the value of the research question. We have amended the introduction to make it more focused based on reviewers’ helpful comments as follows.

1.2 I would lead the discussion of the existing literature with the paragraph starting, “The largest body of literature comes from individual-level observational studies showing a consistent positive association…” The Vasiljevic study looking at exposure to e-cigarette advertisements does not seem directly relevant. Although I understand that it utilizes an experimental design, it could be cut to shorten the rather long introduction.

Authors response: We have reorganized the discussion of existing literature in the revised manuscript. It now begins with observational studies, followed by the experimental study by Vasiljevic and colleagues, and then ecological evidence. The description of the Vasiljevic study has been shortened.

1.3 The authors’ reference #26 should be discussed more fully in the introduction and discussion sections, as it identifies the components of common liability to use tobacco products and could shed light on the proper covariates to include in the SEM.

Authors response: We have added more details of reference #26 (now reference # 15) in the revised manuscript (the middle of the 5^th paragraph in the Introduction and the middle of the second paragraph in Discussion). During the revision, another study using similar method has been published. In this study, an inverse association was found between e-cigarette use and subsequent cigarette smoking using data from NYTS. We have added this study in the revised manuscript (ref. #16).

1.4 The discussion of ecological studies is lengthy and could be shortened.

Authors response: We have shortened the discussion about ecological studies in the revised manuscript.

1.5 Common liability theory should be introduced and described in the introduction, as it underlies the whole project. What is it, how is it measured, why is it appropriate for this project?

Authors response: In the revised manuscript, we have added more details about the common liability theory (the beginning of the 5^th paragraph of the Introduction).

2. Methods

2.1 SEM is not that commonly used by epidemiologists. The paper would be more accessible if it included a brief introduction to SEM, including model selection, model evaluation, and how to interpret the results. The authors should explain why SEM is the right way to analyze a hypothesis based in common liability theory.

Authors response: We have added a brief introduction of SEM and why we think SEM is appropriate for this analysis based on the common liability theory (2^nd paragraph under Analysis Approach).

2.2 The authors used data from Wave 1 (2013-2014) and Wave 2 (2014-2015) of the PATH study. Were PATH Wave 3 (2015-2016) data available and considered? If available but not included, why not?

Authors response: PATH wave 3 data were not available when we started this project. During the course of the project, they became available. We did repeat the analysis using wave 2 and 3 data, and the results are similar. We have added estimates using wave 2 and 3 data in the Results section of the revised manuscript and in the new Table 3.
Nonetheless, we consider wave 1 and 2 data our primary focus because it is what we set out to do. Also, PATH wave 1 is the true baseline cohort, which is a representative sample of youth. Wave 2 is a follow-up of the wave 1 cohort with ‘shadow’ youth (those younger than 12) sampled at wave 1. In addition, for longitudinal studies like PATH, attrition occurs at each follow-up. When using wave 2 and 3 data, attrition may play a larger role.

2.3 Are the questions the same in Wave 2 for those who are 18? If so, have you considered running a sensitivity model that includes the 18-year-olds? Have other authors made this same decision to exclude them? How many Wave 1 youth were excluded because they had aged up by Wave 2? It may make less sense for future studies to make this cut-off considering changes in the minimum legal age to purchase tobacco products.

Authors response: We did discuss whether we should include aged-up youth in the analysis, and we decided not to because the focus of this study is on youth smoking onset. During wave 1 and 2 data collection (2013-2015), cigarettes were legal for 18-year-olds to purchase in most places. Risk profiles and mechanisms may differ for underage smoking from of-age smoking. We wanted to retain a focus on youth smoking onset and, therefore, did not include 18 year olds in the current study.

2.4 The authors ran two sets of models, one limited to tobacco products and a second, which they call the ‘expanded liability model’, that includes tobacco products and psychoactive substances. This expanded liability model is not introduced until the results section. It should be described in the methods.

Authors response: We have added a paragraph in the Method section to describe a series of models to explore the sensitivity of the main model results, including the model with additional psychosocial covariates and the model with wave 2 and wave 3 data, as suggested by the reviewers (fourth paragraph in the Analysis section).

2.5 Sex and age were included as covariates. Were any of the other risk factors for smoking available in PATH, such as were identified in authors’ reference 26? If so, why not use those?

Authors response: We have added additional covariates in the series of exploratory analysis described in the revised manuscript. Please see our response to reviewer #1’s comment #2 for a detailed explanation.

2.6 Please provide additional information on missing information. The only mention of it is as it relates to the covariates of age and sex. The authors report that this information was obtained from the Demographics module, which if missing was taken from the household screening roster. Was there missing information for the questions related to tobacco products, alcohol, cannabis, and other psychoactive drugs. If so, provide numbers and describe how it was handled. If there was limited missing information, that could be noted as a strength. Also, was there evidence that the data were, or were not, missing systematically? This can be assessed by comparing the available information for respondents who answered the substance use questions vs. those who did not.

Authors response: We have added a sentence in the revised manuscript to indicate that for all tobacco use variables, there were <3% missing values. In addition, we specified a robust weighted least square mean and variance adjusted estimator which uses a full weight matrix. Therefore, a participant is included in the model unless the participant has missing values in all indicator variables (i.e., tobacco use and substance use variables). None of wave 1 never smokers had missing values in all of these variables, so we are able to include all never smokers in our model. We have added this information in the last paragraph of the Methods section in the revised manuscript.

3. Results

3.1 Please provide the number of eligible participants at Wave 1 and Wave 2 and report numbers and reasons for any that were excluded. This could be done in the form of a figure ending with the final number included in your analysis.

Authors response: In the revised manuscript, we added a sentence about the number of participants included in the current study:
Among 13,651 participants at wave 1, 11,792 were never smokers, among whom 9,045 remained youth (12-17 years of age) and were followed up for wave 2 assessment.
The sampling procedure of PATH is described in detail in PATH User’s Guide (ref. #39)

3.2 Also, please include a baseline table that provides basic demographic information. This could also be described in text.

Authors response: In the revised manuscript, we have added basic demographics of the sample in Table 1 and a sentence in the first paragraph of the Results section:
Of the 9,045 participants, 51% were males; 64% were 12-14 year olds; and 54% were non-Hispanic whites.

3.3 The titles for tables 1 and 2 indicate that that data is from Wave 1 and Wave 2. We are interested in ever use of the products listed in the table at Wave 1 and ever use of cigarettes at Wave 2. Please clarify what is provided in the table and update the table titles/descriptions.

Authors response: We have adjusted the titles of Table 1 and Table 2 to reflect the estimates are among wave 1 never smokers.

3.4 In fact, perhaps tables 1 and 2 could be combined to include demographic data from Wave 1; ever use of e-cigarette, cigar, pipe, hookah, SLT, bidi, alcohol, cannabis, prescription Ritalin and Adderall, cocaine/crack, stimulants, and other drugs at Wave 1; and ever cigarette use at Wave 3.

Authors response: In the revised manuscript, we have combined the previous Table 1 and 2 into one table (new Table 1).

3.5 I’d suggest placing the model results described in the text in a table.

Authors response: We have added Table 2 which contains model results.

4. Discussion

4.1 The authors conclude that “after accounting for the latent ‘common liability to use tobacco products’ construct, ever e-cigarette use does not predict the onset of smoking among US adolescents.” This statement is supported by the results provided, assuming that the variables considered by the authors reasonably captured the common liability they hypothesized exists. This point – whether or not the covariates included were sufficient – needs further explanation and justification.

Authors response: As we indicated above, we have added additional covariates in the model in our exploratory analyses, and the estimates were very similar to the one from the main model. We think these additional results suggest a certain degree of robustness of the latent ‘common liability’ construct and the main model overall. We have added this information and related discussion in the revised manuscript.
Please also see our response to comment 2.5 and to reviewer #1’s comment #2 for more details.

4.2 The authors identify several appropriate limitations and strengths. However, the limitations should address more explicitly the availability of data to describe smoking propensity, as defined in reference 26 or elsewhere. The authors identify lack of recall bias as a strength of the study, but the interval between waves in PATH is quite short, so recall bias is not a major concern.

Authors response: Regarding concerns about other covariates, we have conducted additional exploratory analyses to incorporate additional covariates related to smoking onset based on previous literature. Please also see our response to comment 2.5 and to reviewer #1’s comment #2.
Regarding recall bias, we understand that the follow-up interval is only a year; however, there has been literature showing inconsistencies in the reporting of tobacco use as well as alcohol drinking behaviors in the youth population. In a cross-sectional setting, a smoker may be more likely to recall other tobacco use and vice versa because they can be correlated behaviors. Therefore, we think it is a noteworthy strength of the current study.

4.3 The discussion section should place the current results into context of what is already known about smoking initiation in youth. The authors note that their findings are in line with a study by Kim et al. (2019) and they should discuss this reference more fully. Several other observational studies are referenced in the introduction and further description of these observational studies might be useful here as well.

Authors response: We have revised both the Introduction and Discussion to provide fuller details of previous studies and their relevance to the current study to help put findings from the current study into context.

In closing, we thank all three reviewers for their helpful and constructive comments. We hope we have provided sufficient information and revision to make the work acceptable for publication.

View more View less

Competing Interests

No competing interests were disclosed.

Back to all reports

Reviewer Report

21 Views

08 Jan 2020 | for Version 1

Arielle S. Selya, Behavioral Sciences Group, Sanford Research, Sioux Falls, USA; Pinney Associates, Inc., Pittsburgh, PA, USA

21 Views Cite this report Responses(1)

Approved With Reservations

The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.
My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?
I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Minor comments:

I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.
On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?
What does the acronym ACASI mean (p.7)?

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Behavioral science, esp. nicotine use and dependence among adolescents

Respond to this report

Responses (1)

Author Response

04 May 2020

Hui Cheng, Regulatory Sciences, Altria Client Services, Richmond, 23219, USA

Dr. Selya’s comments

General comments:

This manuscript focuses on the controversial question of whether e-cigarettes causally lead to later cigarette smoking among adolescents, or whether the use of both conventional cigarettes and e-cigarettes are due to a common liability. The paper uses structural equation modeling to model the pre-existing likelihood of e-cigarette use as a latent factor, finds that e-cigarettes do *not* have a causal effect on later conventional smoking over and above the latent factor. This paper uses an innovative method to address a complicated statistical question. The paper is well-written, and the implications are important. Authors response: We thank the reviewer for recognizing the significance and novelty of the work and the helpful comments. We have revised the original manuscript based on these comments as detailed below.

Major comments:

1. The introduction has an excellent literature review that makes a convincing case for the common liability hypothesis, even using papers that at face value support the “gateway” hypothesis of e-cigarettes but identifying interesting counterpoints in the analyses of these papers.

Authors response: We thank the reviewer for recognizing the value of the research question.

2. My main concern is about the choice to include only substance use variables in the latent factor representing liability to use tobacco products. Propensity to use tobacco products includes a variety of other factors as well (socioeconomic, personality characteristics, risk perception, peer group and family substance use, mental health, etc). Are these other variables available in the PATH study, and if so what was the rationale to restrict only to behavioral tobacco use measures? What would the results look like if other covariates were also included?

Authors response: We agree with the reviewer that the propensity to use tobacco products is multifaceted, including important factors mentioned by the reviewers.
In this study, we were guided by the ‘common-liability’ theory and hypothesized that the use of various tobacco products is driven by an unobserved latent liability to use tobacco products. That is, a single-dimension latent variable (i.e., the liability to use tobacco products) gives rise to the use of different tobacco products. This latent liability to use tobacco products likely varies by socioeconomic, personality characteristics, risk perception, peer influence, and familial history of substance use, mental health etc., which can be precedents, consequences, or both (feedback loops) of tobacco use. That is, our expectation is that the latent variable, which represents an individual’s liability to use tobacco products, is correlated with these other variables. Practically, one complexity to include various other factors in the structural equation framework is that these variables are not necessarily manifestations of a single dimension, which complicates the structure of the measurement model. Due to the above theoretical and practical reasons, we chose to take a simpler theory-driven approach to define the latent construct by tobacco use behaviors and only included sex and age as covariates because they are exogenous to the liability-and-smoking-onset relationship. In an exploratory step, we further expanded the model to include other substances because it has been shown that adolescent substance use is highly opportunistic and tobacco use is highly correlated with other substance use among adolescents in the original submission.
That said, the reviewer’s concern is well taken. We have expanded the model to include aforementioned variables as covariates to the extent that they were assessed in PATH wave 1 survey. Specifically, we took a two-step approach to include additional covariates. First, we added race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanics, and non-Hispanic others), availability of tobacco products in the household (yes/no), and a measure of novelty seeking (“agree” or “strongly agree” to the question “I like new and exciting experiences, even if I have to break the rules. Do you…”). In the second step, we additionally included participant’s self-rated health (excellent/non-excellent), harm perception of cigarettes (“a lot of harm” to the question “How much do you think people harm themselves when they smoke cigarettes”), and participant’s grade (mostly A’s or A’s and B’s vs. others) because these variables are more likely to have feedback loops with tobacco use. These covariates were modeled to correlate with the latent liability construct and to predict the onset of cigarette smoking at wave 2.
The inclusion of these variables induced little change in estimates, although the latent-liability-to-smoking-onset path became marginally significant statistically, possibly due to the loss of precision associated with the additional covariates. Nonetheless, e-cigarette did not predict smoking onset in either model (Additional model 1: β=0.16; 95% CI= -0.04, 0.35; p=0.109; Additional model 2: β=0.16; 95% CI= -0.03, 0.35; p=0.102), and the latent liability of tobacco use predicted smoking onset in the first additional model (β=0.31; 95% CI= 0.01, 0.61; p=0.047) as well as in additional model 2 (β=0.31; 95% CI= 0.01, 0.61; p=0.047).
We observed little change in estimates for the e-cigarette-to-smoking relationship as well as the liability-to-smoking relationship across the four models (no covariates, sex-and-age as covariates, additional model 1, and additional model 2 described above), which suggests that the model is robust to variations of covariates.
In the revised manuscript, we have added this additional information in the Results section and revised the Discussion section accordingly.

3. I would recommend a re-organization of the Discussion, to discuss interpretation of findings, implications, and relation to existing literature first, followed by limitations and strengths.

Authors response: We thank the reviewer for the suggestion. We have moved the ‘Limitation and strengths’ section to the end of the manuscript.

Minor comments:

1. I think a brief description of “standardized threshold” (which appears first in Table 1) would be helpful.

Authors response: We thank the reviewer for bringing it to our attention. After further consideration, we think the unstandardized thresholds are more meaningful than the standardized threshold. In the revised version, we have changed the standardized thresholds to unstandardized thresholds, which represents the ‘difficulty parameter’ of items. We have also added the following footnote for “standardized loading” in Table 1:
“Factor loadings are standardized based on the variances of the continuous latent variables as well as the variances of the outcome variables.”

2. On p. 6, last paragraph, why are exact values not reported for the fit measures (“RMSEA <0.02, CFI and TLI > 0.90”) as they are elsewhere?

Authors response: In the revised version, we have added exact values for these fit indices in the revised version as follows,
“RSMEA=0.015, 90% CI=0.012, 0.017; CFI=0.948, TLI=0.938 for the model without sex and age; RSMEA=0.016, 90% CI=0.015, 0.018; CFI=0.922, TLI=0.905 for the model out sex and age as covariates”
We did not report the exact values in the previous version because we considered the expanded model a post-estimation exploratory step and the results are similar to those of the main model.

3. What does the acronym ACASI mean (p.7)?

Authors response: ACASI stands for audio computer assisted self-interviews. It was defined at first appearance under “Assessment.” Since it only appeared three times in the manuscript, we have replaced the acronyms with its full name in the revised version.

View more View less

Competing Interests

No competing interests were disclosed.

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

[1] 1. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017; 389(10082): 1885–1906. PubMed Abstract | Publisher Full Text | Free Full Text

[2] 2. Dutra LM, Glantz SA: E-cigarettes and National Adolescent Cigarette Use: 2004-2014. Pediatrics. 2017; 139(2): pii: e20162450. PubMed Abstract | Publisher Full Text | Free Full Text

[3] 3. Johnston LD, Miech RA, O'Malley PM, et al.: Monitoring the Future national survey results on drug use: 1975-2017: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research. 2018. Reference Source

[4] 4. Wang TW, Gentzke A, Sharapova S, et al.: Tobacco Product Use Among Middle and High School Students - United States, 2011-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(22): 629–633. PubMed Abstract | Publisher Full Text | Free Full Text

[5] 5. Johnston LD, Miech RA, O'Malley PM, et al.: Teen use of any illicit drug other than marijuana at new low same true for alcohol. 2016. Reference Source

[6] 6. Collins LK, Villanti AC, Pearson JL, et al.: Frequency of Youth E-Cigarette, Tobacco, and Poly-Use in the United States, 2015: Update to Villanti et al., "Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health". Nicotine Tob Res. 2017; 19(10): 1253–1254. PubMed Abstract | Publisher Full Text | Free Full Text

[7] 7. Warner KE: How to Think-Not Feel-about Tobacco Harm Reduction. Nicotine Tob Res. 2019; 21(10): 1299–1309. PubMed Abstract | Publisher Full Text

[8] 8. Vasiljevic M, St John Wallis A, Codling S, et al.: E-cigarette adverts and children's perceptions of tobacco smoking harms: an experimental study and meta-analysis. BMJ Open. 2018; 8(7): e020247. PubMed Abstract | Publisher Full Text | Free Full Text

[9] 9. Miech R, Patrick ME, O'Malley PM, et al.: E-cigarette use as a predictor of cigarette smoking: results from a 1-year follow-up of a national sample of 12th grade students. Tob Control. 2017; 26(e2): e106–e111. PubMed Abstract | Publisher Full Text | Free Full Text

[10] 10. Leventhal AM, Strong DR, Kirkpatrick MG, et al.: Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015; 314(7): 700–707. PubMed Abstract | Publisher Full Text | Free Full Text

[11] 11. Watkins SL, Glantz SA, Chaffee BW: Association of Noncigarette Tobacco Product Use With Future Cigarette Smoking Among Youth in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2015. JAMA Pediatr. 2018; 172(2): 181–187. PubMed Abstract | Publisher Full Text | Free Full Text

[12] 12. Berry KM, Fetterman JL, Benjamin EJ, et al.: Association of Electronic Cigarette Use With Subsequent Initiation of Tobacco Cigarettes in US Youths. JAMA Netw Open. 2019; 2(2): e187794. PubMed Abstract | Publisher Full Text | Free Full Text

[13] 13. Soneji S, Barrington-Trimis JL, Wills TA, et al.: Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017; 171(8): 788–797. PubMed Abstract | Publisher Full Text | Free Full Text

[14] 14. Glasser A, Abudayyeh H, Cantrell J, et al.: Patterns of E-Cigarette Use Among Youth and Young Adults: Review of the Impact of E-Cigarettes on Cigarette Smoking. Nicotine Tob Res. 2019; 21(10): 1320–1330. PubMed Abstract | Publisher Full Text

[15] 15. Polosa R, Russell C, Nitzkin J, et al.: A critique of the US Surgeon General's conclusions regarding e-cigarette use among youth and young adults in the United States of America. Harm Reduct J. 2017; 14(1): 61. PubMed Abstract | Publisher Full Text | Free Full Text

[16] 16. Jamal A, Gentzke A, Hu SS, et al.: Tobacco Use Among Middle and High School Students - United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2017; 66(23): 597–603. PubMed Abstract | Publisher Full Text | Free Full Text

[17] 17. Levy DT, Warner KE, Cummings KM, et al.: Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check. Tob Control. 2019; 28(6): 629–635. PubMed Abstract | Publisher Full Text | Free Full Text

[18] 18. Pesko MF, Hughes JM, Faisal FS: The influence of electronic cigarette age purchasing restrictions on adolescent tobacco and marijuana use. Prev Med. 2016; 87: 207–212. PubMed Abstract | Publisher Full Text

[19] 19. Friedman AS: How does electronic cigarette access affect adolescent smoking? J Health Econ. 2015; 44: 300–308. PubMed Abstract | Publisher Full Text

[20] 20. Abouk R, Adams S: Bans on electronic cigarette sales to minors and smoking among high school students. J Health Econ. 2017; 54: 17–24. PubMed Abstract | Publisher Full Text

[21] 21. Etter JF, Bugey A: E-cigarette liquids: Constancy of content across batches and accuracy of labeling. Addict Behav. 2017; 73: 137–143. PubMed Abstract | Publisher Full Text

[22] 22. Kozlowski LT, Warner KE: Adolescents and e-cigarettes: Objects of concern may appear larger than they are. Drug Alcohol Depend. 2017; 174: 209–214. PubMed Abstract | Publisher Full Text

[23] 23. Vanyukov MM, Ridenour TA: Common liability to drug addictions: theory, research, practice. Drug Alcohol Depend. 2012; 123(Suppl 1): S1–2. PubMed Abstract | Publisher Full Text | Free Full Text

[24] 24. Vanyukov MM, Tarter RE, Kirillova GP, et al.: Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 2012; 123(Suppl 1): S3–17. PubMed Abstract | Publisher Full Text | Free Full Text

[25] 25. Silveira ML, Conway KP, Green VR, et al.: Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Drug Alcohol Depend. 2018; 191: 25–36. PubMed Abstract | Publisher Full Text | Free Full Text

[26] 26. Kim S, Selya AS: The Relationship Between Electronic Cigarette Use and Conventional Cigarette Smoking Is Largely Attributable to Shared Risk Factors. Nicotine Tob Res. 2019; pii: ntz157. PubMed Abstract | Publisher Full Text

[27] 27. Leventhal AM, Strong DR, Kirkpatrick MG, et al.: Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015; 314(7): 700–707. PubMed Abstract | Publisher Full Text | Free Full Text

[28] 28. Penzes M, Foley KL, Nădășan V, et al.: Bidirectional associations of e-cigarette, conventional cigarette and waterpipe experimentation among adolescents: A cross-lagged model. Addict Behav. 2018; 80: 59–64. PubMed Abstract | Publisher Full Text | Free Full Text

[29] 29. East K, Hitchman SC, Bakolis I, et al.: The Association Between Smoking and Electronic Cigarette Use in a Cohort of Young People. J Adolesc Health. 2018; 62(5): 539–547. PubMed Abstract | Publisher Full Text | Free Full Text

[30] 30. United States Department of Health and Human Services: Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2012. PubMed Abstract

[31] 31. Fischer JA, Najman JM, Williams GM, et al.: Childhood and adolescent psychopathology and subsequent tobacco smoking in young adults: findings from an Australian birth cohort. Addiction. 2012; 107(9): 1669–1676. PubMed Abstract | Publisher Full Text

[32] 32. Farmer RF, Seeley JR, Kosty DB, et al.: Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood. Psychol Addict Behav. 2015; 29(3): 541–551. PubMed Abstract | Publisher Full Text | Free Full Text

[33] 33. Patrick ME, Schulenberg JE: Prevalence and predictors of adolescent alcohol use and binge drinking in the United States. Alcohol Res. 2013; 35(2): 193–200. PubMed Abstract | Free Full Text

[34] 34. Pedersen MU, Thomsen KR, Heradstveit O, et al.: Externalizing behavior problems are related to substance use in adolescents across six samples from Nordic countries. Eur Child Adolesc Psychiatry. 2018; 27(12): 1551–1561. PubMed Abstract | Publisher Full Text

[35] 35. Leventhal AM, Strong DR, Sussman S, et al.: Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016; 73: 71–78. PubMed Abstract | Publisher Full Text | Free Full Text

[36] 36. United States: Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files User Guide. In: Services DoHaH, ed. Ann Arbor, Michigan 48106: Inter-university Consortium for Political and Social Research. 2017.

[37] 37. Steiger JH: Structural Model Evaluation and Modification: An Interval Estimation Approach. Multivariate Behav Res. 1990; 25(2): 173–180. PubMed Abstract | Publisher Full Text

[38] 38. Bentler PM: Comparative fit indexes in structural models. Psychol Bull. 1990; 107(2): 238–246. PubMed Abstract | Publisher Full Text

[39] 39. Hu Lt, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal. 1999; 6(1): 1–55. Publisher Full Text

[40] 40. Bentler PM, Bonett DG: Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980; 88(3): 9. Publisher Full Text

[41] 41. United States Department of Health and Human Services; National Institutes of Health; National Institute on Drug Abuse; et al.: Population Assessment of Tobacco and Health (PATH) Study [United States] Public-Use Files. Inter-university Consortium for Political and Social Research [distributor], 2019-11-11. http://www.doi.org/10.3886/ICPSR36498.v9

[42] 42. Latkin CA, Vlahov D, Anthony JC: Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993; 88(4): 517–526. PubMed Abstract | Publisher Full Text

[43] 43. Adams J, Parkinson L, Sanson-Fisher RW, et al.: Enhancing self-report of adolescent smoking: the effects of bogus pipeline and anonymity. Addict Behav. 2008; 33(10): 1291–1296. PubMed Abstract | Publisher Full Text

[44] 44. United States Substance Abuse and Mental Health Services Administration: 2016 National Survey on Drug Use and Health: Methodological summary and definitions. In: Quality. CfBHSa, ed. Rockville, MD: United States Substance Abuse and Mental Health Services Administration; 2017. Reference Source

[45] 45. Lapouse R: Problems in studying the prevalence of psychiatric disorder. Am J Public Health Nations Health. 1967; 57(6): 947–954. PubMed Abstract | Publisher Full Text | Free Full Text

[46] 46. Falconer D: The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet. 1965; 29(1): 51–76. Publisher Full Text

[47] 47. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; et al.: Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018. PubMed Abstract | Publisher Full Text

[48] 48. Etter JF: Gateway effects and electronic cigarettes. Addiction. 2018; 113(10): 1776–1783. PubMed Abstract | Publisher Full Text

[49] 49. Schneider S, Diehl K: Vaping as a Catalyst for Smoking? An Initial Model on the Initiation of Electronic Cigarette Use and the Transition to Tobacco Smoking Among Adolescents. Nicotine Tob Res. 2016; 18(5): 647–653. PubMed Abstract | Publisher Full Text

[50] 50. Abrams DB, Glasser AM, Pearson JL, et al.: Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annu Rev Public Health. 2018; 39: 193–213. PubMed Abstract | Publisher Full Text

[51] 51. Villanti AC, Pearson JL, Glasser AM, et al.: Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health. Nicotine Tob Res. 2017; 19(11): 1345–1350. PubMed Abstract | Publisher Full Text | Free Full Text

[52] 52. Hair EC, Romberg AR, Niaura R, et al.: Longitudinal Tobacco Use Transitions Among Adolescents and Young Adults: 2014-2016. Nicotine Tob Res. 2019; 21(4): 458–468. PubMed Abstract | Publisher Full Text

E-cigarette use and onset of first cigarette smoking among adolescents: An empirical test of the ‘common liability’ theory

Abstract

Keywords

Introduction

Methods

Study population and sample

Assessments

Analysis approach

Figure 1. Depiction of a conceptual structural equation model to predict the onset of first cigarette smoking by e-cigarette use adjusting for a latent ‘liability to use tobacco’ construct.

Results

Table 1. Estimated occurrence (%) of lifetime ever use of tobacco products, factor loadings, and thresholds from confirmatory factor analysis.

Table 2. Estimated occurrence (%) of lifetime ever use of tobacco products, alcohol, cannabis, and other psychoactive drugs, factor loadings, and thresholds from confirmatory factor analysis.

Discussion

Limitations and strengths

Interpretation of findings, implications, and future directions

Data availability

Underlying data

Acknowledgements

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated